Rna polymerase function

Rna polymerase function DEFAULT

RNA polymerase structure, function, regulation, dynamics, fidelity and roles in GENE EXPRESSION

1. (a) Iyer LM, Koonin EV, Aravind L. BMC Struct Biol. 2003;3:1.[PMC free article] [PubMed] [Google Scholar](b) Iyer LM, Aravind L. J Struct Biol. 2012;179:299.[PMC free article] [PubMed] [Google Scholar]

2. Vassylyev DG, Vassylyeva MN, Perederina A, Tahirov TH, Artsimovitch I. Nature. 2007;448:157. [PubMed] [Google Scholar]

3. Humphrey W, Dalke A, Schulten K. J Mol Graph. 1996;14:33. [PubMed] [Google Scholar]

4. (a) Bernard G, Chouery E, Putorti ML, Tetreault M, Takanohashi A, Carosso G, Clement I, Boespflug-Tanguy O, Rodriguez D, Delague V, Abou Ghoch J, Jalkh N, Dorboz I, Fribourg S, Teichmann M, Megarbane A, Schiffmann R, Vanderver A, Brais B. Am J Hum Gen. 2011;89:415.[PMC free article] [PubMed] [Google Scholar](b) Tetreault M, Choquet K, Orcesi S, Tonduti D, Balottin U, Teichmann M, Fribourg S, Schiffmann R, Brais B, Vanderver A, Bernard G. Am J Hum Gen. 2011;89:652.[PMC free article] [PubMed] [Google Scholar]

5. Hurwitz J. J Biol Chem. 2005;280:42477. [PubMed] [Google Scholar]

6. Krummel B, Chamberlin MJ. J Mol Biol. 1992;225:221. [PubMed] [Google Scholar]

7. Uptain SM, Kane CM, Chamberlin MJ. Ann Rev Biochem. 1997;66:117. [PubMed] [Google Scholar]

8. (a) Komissarova N, Kashlev M. J Biol Chem. 1997;272:15329. [PubMed] [Google Scholar](b) Nudler E, Mustaev A, Lukhtanov E, Goldfarb A. Cell. 1997;89:33. [PubMed] [Google Scholar]

9. von Hippel PH. Science. 1998;281:660. [PubMed] [Google Scholar]

10. Toulme F, Mosrin-Huaman C, Artsimovitch I, Rahmouni AR. J Mol Biol. 2005;351:39. [PubMed] [Google Scholar]

11. Cheung AC, Cramer P. Nature. 2011;471:249. [PubMed] [Google Scholar]

12. (a) Nechaev S, Adelman K. BBA. 2011;1809:34.[PMC free article] [PubMed] [Google Scholar](b) Nechaev S, Fargo DC, dos Santos G, Liu L, Gao Y, Adelman K. Science. 2010;327:335.[PMC free article] [PubMed] [Google Scholar]

13. Landick R. Biochem Soc Trans. 2006;34:1062. [PubMed] [Google Scholar]

14. Artsimovitch I, Landick R. PNAS USA. 2000;97:7090.[PMC free article] [PubMed] [Google Scholar]

15. Kireeva M, Nedialkov YA, Gong XQ, Zhang C, Xiong Y, Moon W, Burton ZF, Kashlev M. Methods. 2009;48:333.[PMC free article] [PubMed] [Google Scholar]

16. (a) Cheung AC, Cramer P. Cell. 2012;149:1431. [PubMed] [Google Scholar](b) Wang D, Bushnell DA, Westover KD, Kaplan CD, Kornberg RD. Cell. 2006;127:941.[PMC free article] [PubMed] [Google Scholar](c) Vassylyev DG, Vassylyeva MN, Zhang J, Palangat M, Artsimovitch I, Landick R. Nature. 2007;448:163. [PubMed] [Google Scholar](d) Zhang Y, Feng Y, Chatterjee S, Tuske S, Ho MX, Arnold E, Ebright RH. Science. 2012;338:1076.[PMC free article] [PubMed] [Google Scholar]

17. Burgess RR, Travers AA, Dunn JJ, Bautz EK. Nature. 1969;221:43. [PubMed] [Google Scholar]

18. Bieniossek C, Papai G, Schaffitzel C, Garzoni F, Chaillet M, Scheer E, Papadopoulos P, Tora L, Schultz P, Berger I. Nature. 2013;493:699. [PubMed] [Google Scholar]

19. (a) Compe E, Egly JM. Nat Rev Mol Cell Biol. 2012;13:343. [PubMed] [Google Scholar](b) Egly JM, Coin F. DNA repair. 2011;10:714. [PubMed] [Google Scholar]

20. Spedale G, Timmers HT, Pijnappel WW. Genes & Dev. 2012;26:527.[PMC free article] [PubMed] [Google Scholar]

21. (a) Conaway RC, Conaway JW. BBA. 2013;1829:69.[PMC free article] [PubMed] [Google Scholar](b) Malik S, Roeder RG. Nature Rev Gen. 2010;11:761.[PMC free article] [PubMed] [Google Scholar]

22. Roy AL, Sen R, Roeder RG. Trends in Immunol. 2011;32:532.[PMC free article] [PubMed] [Google Scholar]

23. (a) Tomson BN, Arndt KM. BBA. 2013;1829:116.[PMC free article] [PubMed] [Google Scholar](b) Smolle M, Workman JL. BBA. 2013;1829:84.[PMC free article] [PubMed] [Google Scholar]

24. (a) Smith E, Shilatifard A. Genes & Dev. 2013;27:1079.[PMC free article] [PubMed] [Google Scholar](b) Beck DB, Oda H, Shen SS, Reinberg D. Genes & Dev. 2012;26:325.[PMC free article] [PubMed] [Google Scholar]

Sours: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3900282/

Bacterial RNA Polymerase-DNA Interaction—The Driving Force of Gene Expression and the Target for Drug Action

Introduction

Bacterial multisubunit DNA-dependent RNA polymerase (RNAP) is the key enzyme of gene expression and a target of regulation. It is responsible for the synthesis of all RNAs in the cell using ribonucleoside triphosphates (NTPs) substrates. The core enzyme consists of five evolutionarily conserved subunits (α2ββ′ω) with a total molecular weight of ~380 kDa (Borukhov and Nudler, 2008). Although catalytically active, the core enzyme alone is unable to recognize specific promoter sequences, or melt the DNA and initiate transcription. For this, it associates with one of several specificity factors, σ (20~70 kDa), to form RNAP holoenzyme (α2ββ′ωσ) (Murakami and Darst, 2003; Decker and Hinton, 2013). In all bacterial species, most housekeeping genes are transcribed by holoenzyme of one major sigma factor, such as σ70 in E. coli or σA in Thermus thermophilus. Binding of alternative σ factors generates multiple forms of holoenzyme that can utilize different classes of promoters under various growth conditions and in response to environmental cues. The number of σ factors in different bacterial species varies widely from 1 in Mycoplasma genitalium to 7 in E. coli to 63 in Streptomyces coelicolor. Many regulatory factors besides σ can modulate RNAP's ability to recognize promoters and initiate transcription, modify its enzymatic functions and properties (Gruber and Gross, 2003).

Overview of RNAP Structure

In the last 16 years, a wealth of structural information on bacterial RNAPs core and holoenzymes was made available. Initially, the high resolution (2.5~4.5 Å) X-ray crystal structures of RNAP and RNAP complexes with nucleic acids, regulatory factors, and small-molecule inhibitors were obtained using thermophilic organisms, T. thermophilus (Tth) and T. aquaticus (Taq). Beginning in 2013, high-resolution structures of E. coil (Eco) RNAP holoenzyme and its complexes with nucleic acid and inhibitors began to emerge from several groups. Altogether more than 24 high resolution structures of RNAP/RNAP complexes to date have been deposited to database (Zhang et al., 2012, 2014; Bae et al., 2013, 2015a,b), (Bae et al., 2015c; Molodtsov et al., 2013, 2015; Murakami, 2013; Sarkar et al., 2013), (Zuo et al., 2013; Basu et al., 2014; Degen et al., 2014; Feng et al., 2015, 2016; Liu et al., 2015, 2016; Yang et al., 2015b; Zuo and Steitz, 2015). These include: the structures of Taq core; Eco core with transcription factor, RapA; Taq, Tth, and Eco holoenzymes and open promoter complexes; Tth ternary elongation complexes with and without transcription factors (Gfh1, GreA); Taq and Tth RNAP complexes with small-molecule inhibitors and antibiotics. Structural data compilation was also aided by high-resolution structures (1.8–2.9 Å) of sub-domains of Eco RNAP subunits β′, α, and σ, and their complexes with DNA and regulatory factors. For a comprehensive list of currently available bacterial RNAP structures, see the recent review (Murakami, 2015). Together with information gained from a wide range of biochemical, biophysical, and genetic studies, these data refine our understanding of bacterial RNAP structure-function and provide a broad view of transcription process and its regulation.

The overall structure of a bacterial RNAP core enzyme resembles a crab claw, with the two clamps representing β and β′ subunits (Figure 1). The clamps are joined at the base by the N-terminal domains of σ-dimer (αNTDs) serving as a platform for RNAP assembly. σI-NTD and αII-NTD contact mostly β and β′ subunits, respectively. The C-terminal domains of α-dimer (αCTD), each tethered to NTD through a flexible linker, project out from the side of RNAP facing upstream DNA. The large internal cleft between β and β′ clamps is partitioned into the main “primary channel” that accommodates downstream dsDNA and RNA-DNA hybrid; the “secondary channel,” which serves as the site for NTP entry; and the “RNA exit channel” which is involved in RNA/DNA hybrid strand separation and interactions with RNA hairpins during pausing and termination. The active center is located on the back wall of the primary channel, at the center of the claw, where the catalytic loop with three aspartates holding essential Mg2+ ion resides. A long α-helical “bridge” (bridge helix, BH) connecting the β and β′ clamps, the two flexible α-helices of the “trigger” loop (TL), and an extended loop (F-loop), together with the catalytic loop, comprise the active center (reviewed in Nudler, 2009). The ω subunit is bound near the β′ C-terminus at the bottom pincer, serving as a β′ chaperone.

www.frontiersin.org

Figure 1. Structural overview of RNAP core. Structure of Taq RNAP core (PDB:1HQM; Zhang et al., 1999) shown in ribbons in two rotational views, using Molsoft ICM Pro program. Left panel, 2° channel view; right panel, main channel view. The structure is represented as colored ribbons (αI, olive; αII, light gray; β, yellow; β′, cyan; ω, blue) with important domains and structural elements indicated. The directions of primary, secondary and RNA exit channels are indicated by large arrows. Mg2+ ion is shown as a small magenta sphere. The structures of β′ trigger loop (TL), β′ rudder, β′ lid, β′ zipper, and β′ switch-2 regions are modeled using the structure of Tth holoenzyme (PDB: 1IW7; Vassylyev et al., 2002). The Tth β′ nonconserved domain (NCD1, G164-S449) is not shown.

In the structure of σ70-holoenzyme, the bulk of the σ subunit (domains σ1–σ3) is bound on the core surface at the entrance to the major cleft, except for the linker connecting σ domains 3 and 4 (σ3–4 linker containing conserved region σ3.2), which threads through the primary channel, reaches the catalytic pocket with its hairpin loop (σ finger), and comes out from the RNA exit channel, almost completely blocking it (Figure 2). The rest of σ is wedged between the β and β′ clamps at the upstream side of the core enzyme, creating a wall that partially blocks the opening of the primary channel. Transition from core to holoenzyme is accompanied by partial closing of the β,β′ clamps by ~5 Å and movement of the flap domain (tip helix) induced by σ4 by ~12 Å (Vassylyev et al., 2002). The σ2, σ3, and σ4 domains are optimally positioned to contact the −10, extended −10, and −35 elements of the promoter DNA, respectively. In the crystal structures of Eco holoenzyme, consistent with previous biophysical studies (Mekler et al., 2002), σ region 1.1 is located in the downstream dsDNA binding region, blocking the access to DNA (Bae et al., 2013; Murakami, 2013). This location of σ1.1 explains why nonspecific transcription initiation by σ70-holoenzyme at promoterless DNA sequences is very low (Shorenstein and Losick, 1973). The σ-core interface is extensive with multiple cooperative contacts (Sharp et al., 1999; Gruber et al., 2001; Murakami and Darst, 2003), explaining the high stability of the σ-core association (KD ~0.3 nM; Maeda et al., 2000). However, most of these contacts appear to be relatively weak (Vassylyev et al., 2002; Borukhov and Nudler, 2003), which allows alternate σ factors to successfully compete for binding to core. The conserved regions 2.1 and 2.2 of s2 make the most stable contacts with the upstream β′ clamp helices—the major s docking site (Figure 2). σ4 interacts with the β-flap domain, with the C-terminus of σ contacting the β-flap tip. In the presence of specific activators, σ4 also interacts with σI-CTD. In the recent structure of σS-initation complex, σS regions from 1.2 to 4.2 display the same fold as σ70, including the linker 3.2 that inserts into the active site pocket (Liu et al., 2016). σS lacks the non-conserved domain present in σ70, which may explain its lower binding affinity to core (KD ~4 nM) (Maeda et al., 2000).

www.frontiersin.org

Figure 2. Structural overview of RNAP holoenzyme and σ-DNA interactions. (A) The structure of Tth σA-holoenzyme is shown in molecular surface views with color coding as follows: αI, slate gray; αII, light gray; β, yellow; β′, cyan, σ, magenta, ω, dark cyan. Locations of conserved σ domains are indicated. The catalytic Mg2+ ion is shown as a small magenta sphere. The N-terminal domain of Eco σ70 carrying region 1.1 is modeled from the structure of Eco holoenzyme (PDB: 4YG2, Murakami, 2013) and shown as a red surface. Left panel, 2° channel view (as in Figure 1); right panel is obtained by rotation of the left panel view by 180° around the vertical axis, with the β subunit removed to reveal the location of σ3.2 finger region (colored light magenta) and σ4 occupying the RNA exit channel. (B) The structural and functional organization of σ. Top, a ribbon view of σA from Tth holoenzyme structure (PDB: 1IW7; Vassylyev et al., 2002) shown on the right panel in (A). Colored regions correspond to the evolutionarily conserved domains of σ as shown in the functional map of σ70 below. Bottom diagram, a linear representation of σ polypeptide with structural domains and conserved regions shown as numbered and color-coded boxes. Underneath is a diagram of DNA promoter regions showing interactions made by DNA-binding domains of σ, αCTD β′ zipper, and CRE-binding β lobe-2 elements.

Overview of the Transcription Cycle

Transcription process consists of three major stages: initiation, elongation, and termination. In bacteria, initiation occurs through five steps (Figure 3; reviewed in Murakami and Darst, 2003; Saecker et al., 2011).

www.frontiersin.org

Figure 3. Schematic overview of the main steps in transcription initiation. RNAP is shown as a blue oval with the main channel cleft. αCTD is depicted as gray spheres connected to RNAP by flexible linkers (curved lines). σ domains are represented as colored ovals, except for σ3.2 which is drawn as a magenta curvy line connecting σ4 and σ3. The DNA t-strand and nt-strand are colored green and orange, respectively. The nascent RNA is shown as a curvy red line in a scrunched RPinit and in an EC with the DNA-hybridized section indicated. The scrunched part of the DNA bubble is shown as loops in RPinit scrunched. Two initiating NTPs are depicted as short red segments near the catalytic site in RPinit. The RNA exit channel and 2° channel are shown as funnels in dotted line. The catalytic Mg2+ ion is shown as small magenta sphere at the end of the 2° channel.

First, RNAP core enzyme, composed of five subunits (α2ββ′ω), binds one of several specificity factors, σ (such as σ70 for transcription of housekeeping genes in Escherichia coli) to form holoenzyme (Eσ70). Second, Eσ70 recognizes and binds promoter DNA, a pair of conserved hexameric sequences present at positions −35 and −10 relative to the transcription start site (TSS), where it forms a closed promoter complex (RPc). Sequences immediately upstream and downstream of the −10 element including “−15TG−14 extended −10” (Keilty and Rosenberg, 1987), “−15 enhancer” (or “−17/−18 zipper-binding”; Liu et al., 2004; Yuzenkova et al., 2011) and “−6GGGA−3 discriminator” (Feklistov et al., 2006; Haugen et al., 2006) regions, and A/T-rich regions upstream of the −35 element [“UP-element” at −45; −65 (Ross et al., 1993)], also contribute to specific recognition by the Eσ70 (reviewed in Decker and Hinton, 2013; Feklístov et al., 2014). Third, RPc undergoes a series of conformational changes (isomerization) through several transition states (such as intermediate complex, RPi), to form an open promoter complex (RPo). Isomerization results in unwinding of DNA duplex around the −10 region (typically, between nt −11 and +2- +4) and creates a 12–15 nt long transcription bubble, a hallmark of RPo. Fourth, in the presence of rNTPs, RPo converts to an initial transcribing complex (RPinit), forms the first phosphodiester bond between rNTPs positioned at +1 and +2 sites and then begins the RNA synthesis. During the synthesis beyond dinucleotide, RPinit undergoes “scrunching” whereby the downstream DNA (from +2 to +15) is pulled into the enzyme to be transcribed, resulting in bubble expansion (up to ~25 nt), while the upstream DNA-RNAP contacts remain intact (Kapanidis et al., 2006; Revyakin et al., 2006). At the same time, growth of nascent RNA beyond 6-mer is obstructed by the presence of σ3–4 linker in the RNA exit channel (Basu et al., 2014; Bae et al., 2015b). Biochemical data suggest that stress associated with DNA scrunching, and more importantly the steric clash between RNA 5′-end and σ3–4 (σ finger), together cause RNAP to repetitively synthesize and release short RNAs without leaving the promoter (abortive initiation; Sen et al., 1998; Murakami et al., 2002b; Kulbachinskiy and Mustaev, 2006; Samanta and Martin, 2013; Winkelman et al., 2016b). In the final step, the enzyme synthesizes an RNA of a critical length (typically 11–15 nt, of which ~9 nt are in the transcription bubble as RNA–DNA hybrid), removes the exit channel blockage, and escapes from promoter, entering the elongation stage of transcription. During this transition, RNAP undergoes global conformational change, which leads to the loss of RNAP-promoter DNA contacts, gradual σ dissociation, and formation of a highly stable and processive ternary elongation complex (EC) (Murakami and Darst, 2003).

Throughout elongation stage, the size of the transcription bubble in the EC remains constant at ~12 ± 1 nt, and the size of RNA/DNA hybrid is maintained at ~9–10 bp (Svetlov and Nudler, 2009; Kireeva et al., 2010). Elongating RNAP can transcribe DNA over long distances (>10,000 bp) without dissociation and release of RNA product. However, elongation does not proceed at a uniform rate; monotonous movement of RNAP can be interrupted by various roadblocks imposed by certain DNA sequences, DNA topology, lesions in transcribed DNA template, RNA secondary structures, DNA-binding proteins, DNA replication and repair machineries, ribosomes, other transcription complexes, RNAP-binding transcription factors (including σ70 that can be recruited back to EC upon encountering promoter-like sequences; Goldman et al., 2015; Sengupta et al., 2015), and small-molecule effectors (ppGpp) (Landick, 2006; Perdue and Roberts, 2011; Nudler, 2012; Imashimizu et al., 2014; Belogurov and Artsimovitch, 2015; Kamarthapu et al., 2016). Eventually, RNAP encounters a termination signal—a 20–35 nt-long G/C-rich RNA sequence of dyad symmetry that forms a hairpin structure immediately followed by a 7–9 nt-long stretch of Us (Yarnell and Roberts, 1999). During termination, RNAP releases the nascent transcript and dissociates from the DNA template, after which it can rebind a σ factor and start a new round of transcription. Under certain conditions, transcription termination can also be induced by termination factors ρ and Mfd (Roberts and Park, 2004; Kriner et al., 2016).

In this review, we discuss recent findings that elucidate molecular details of RNAP-DNA interactions during initiation the transcription cycle. Specifically, we will describe most current advances in the structural and biochemical studies of the molecular mechanisms underlying promoter recognition and RPo formation, activation of initiation, and promoter escape. Finally, we will review the mechanisms of action of known antibacterial drugs that specifically target RNAP.

Molecular Details of Transcription Initiation and its Activation

Structure of Holoenzyme-Promoter DNA Complexes

Promoter Recognition and Binding: Closed Promoter Complex (RPc)

Currently, there are no high resolution structure of the RPC, but a model of Taq RPc based on the existing structural, biochemical, biophysical, and genetic data has been proposed (Murakami et al., 2002a; Murakami and Darst, 2003). In the model, promoter dsDNA rests on the outer surface of the RNAP main channel, bound mostly by σ (Figure 3). RNAP contacts with −10, extended −10, and −35 elements of the promoter are established by σ2, σ3, and σ4 (regions 2.2–2.4, 3.0, and 4.2, respectively) through polar and van der Waals contacts. Additionally, residues of two αCTD helix–hairpin–helix motifs (Eco R265, N294, and K298) may contact A/T-rich sequences in the minor groove of the UP element at positions from −40 to −60 and up to −90 (Ross et al., 2001; Benoff et al., 2002). These weak but specific UP/αCTD interactions contribute to RPc formation (Haugen et al., 2008). However, with the exception of the −35 element/σ4 and the −12 bp of −10 element/σ2 contacts, other upstream dsDNA-RNAP interactions are mostly non-specific and weak, which makes RPc intrinsically unstable. Nonetheless, these interactions may provide initial promoter recognition and increase its occupancy by RNAP. They may also induce local distortion in DNA structure facilitating subsequent steps in transcription initiation: DNA melting, strand separation and template strand insertion into the active site cleft. For instance, the RNAP-bound DNA in the RPc appears to be bent or kinked at three places: around −25, to accommodate variable spacer length, at −35, induced by insertion of s4 helix-turn-helix motif into the major groove, and at −45, induced by αCTD-DNA minor groove interactions (Benoff et al., 2002). The DNA bending at −35 aids in the proper binding of upstream DNA by αCTD and upstream transcription activators. Additionally, recent structural and biochemical data on RPo (see below) implicate conserved residues of σ3 region 3.0 (Tth H278 and R274) and β′ zipper (Tth Y34 and R35, T36, and L37) in the recognition of non-canonical −17/−18 “Z-element” which contribute to promoter recognition and binding in RPc (Yuzenkova et al., 2011; Bae et al., 2015b). Notably, σ1.1 blocks the access to downstream (ds and ss) DNA in the main channel by binding with its negatively charged face (mimicking DNA) to the basic surface of the β lobe-2 and the downstream β′ clamp (Murakami, 2013). However, the opposite, positively charged face of σ1.1 is positioned to interact with the downstream DNA which may further stabilize RPc. Subsequent steps leading to displacement of σ1.1 by downstream DNA during transition to RPo are poorly understood, but are thought to involve β′-clamp opening triggered by upstream promoter DNA binding and initial DNA unwinding around −11 (see below).

Recently an alternative view on initial promoter recognition and RPc formation was proposed based on structural and biochemical data (Feklistov and Darst, 2011; Zhang et al., 2012; reviewed in Hook-Barnard and Hinton, 2007; Decker and Hinton, 2013; Feklistov, 2013). In this view, except for direct RNAP recruitment by transcription activators that provide sequence-specific DNA recognition, the upstream DNA-RNAP interactions (involving UP and −35 elements) play only an auxiliary role in RPc formation. Instead, initial promoter binding/recognition is accomplished through (i) indirect readout of DNA shape (a distinctive conformational patterns of stacked bases in dsDNA) by RNAP, and (ii) by direct readout of an indispensable −10 element by σ2-specific interaction with two flipped-out consensus nucleotides, −11(A) and −7(T), of nt-strand DNA (see below). These two views on the mechanism of promoter recognition are not mutually exclusive and could be eventually addressed when the structure of RPc becomes available.

Advances in Structural Studies of Open Promoter Complex (RPo)

In the last 3 years several high resolution structures of Tth, Taq, and Eco RPo with different DNA scaffolds have been solved. These include upstream fork and downstream fork promoter DNA (Murakami et al., 2002a; Zhang et al., 2012, 2014; Basu et al., 2014), and complete transcription bubble promoter template with upstream and downstream dsDNA (Bae et al., 2015b; Zuo and Steitz, 2015; Liu et al., 2016). The structures of RPo correlate well and complement each other. Taken together, they reveal the positions of ds and ssDNA (from −36 to +12) in the complex and the key residues of RNAP that make critical interactions with DNA and RNA. Unlike RPc, in RPo both strands of downstream dsDNA up to +12 are fully enclosed inside the RNAP main channel (Figure 4). In RPo, RNAP makes tight contacts with DNA from −36 to −30 and −18 to +9, in agreement with DNA footprinting and crosslinking data (Ross and Gourse, 2009; Winkelman et al., 2015). The RNAP interactions with the upstream portion of ds DNA (from −36 to −12) are similar to that shown in RPc model, however, at −13/−12 the DNA bends sharply by ~90° toward the RNAP. At position −11, the t- and nt-strands separate, and enter different paths for ~13 downstream nucleotides until they form dsDNA at position +3, thus creating the “transcription bubble.”

www.frontiersin.org

Figure 4. Detailed map of protein-nucleic acid interactions in RPo. Central panel shows the surface view of RPo structure of Taq σA-holoenzyme with full bubble promoter DNA (endpoints −36; +12) (PDB: 4XLN; Bae et al., 2015b). The color coding is the same as in Figure 2, except for β which is shown in brown. The displaced σ1.1 domain and the β′-NCD1 are not shown. Part of the β structure is removed (above of the thick gray line) to reveal the inside of the main channel and to show the interactions of σ and β′ with transcription bubble and ds DNA. DNA is shown as a worm in stick representation with t and nt strands colored dark green and yellow, respectively, with the main promoter elements indicated. EXT, extended −10. The small magenta ball indicates the position of catalytic Mg2+. (A–E) Zoomed-in detailed views of different sections of the central panel with key interacting residues and nucleotide positions indicated as sticks (A,B,D) or as surfaces (C,E). Interactions of (A) σ4 with the -35 DNA element; (B) β′ zipper and σ3 with −18/−17 and the extended −10 elements; (C) σ3 and σ2 with −10 element; (D) σ1.2 and β lobe-2 with DSR and CRE of the nt-strand DNA; (E) σ1.2–σ3.2 domains and β′ rudder, lid and switch-2 elements with the t-strand DNA spanning −11 to +1. Panel (E) highlights the interactions between basic patch residues of σ3 with the −11T at the upstream edge of transcription bubble, and the steric clash between the 4 nt-long RNA 5′ terminus and σ3.2 finger.

Upstream DNA (−35, −17/−18, and extended −10 elements)

In two RPo structures that contain a full bubble DNA (Bae et al., 2015b; Zuo and Steitz, 2015), contacts made at −35 region are the same as in isolated σ4 domain/−35 element (Figure 4A) (Campbell et al., 2002). As proposed for RPc, RPo structure demonstrates that duplex DNA upstream of the −10 element (−18 to −12) makes functionally important contacts with conserved residues of β′ zipper, σ3, and σ2 (Figure 4B), mostly through phosphate backbone of the nt-strand (Yuzenkova et al., 2011; Bae et al., 2015b; Feng et al., 2016). These contacts were not visible in the low resolution structures of RNAP with nucleic acids. The sequence specific recognition of extended −10 element (−15T:A, −14G:C) by conserved residues of σ2/σ3, E281 (Eco E458), R264 (R441), and V277 (V454), stabilizes RPo and can substitute for a poor or absent −35 element (Keilty and Rosenberg, 1987). Mutational analysis shows that all three residues are essential for promoter recognition (Daniels et al., 1990).

−10 element

The initial DNA melting starts at the A:T bp at position −11 (Chen and Helmann, 1997; Lim et al., 2001), when −11A flips out from the duplex DNA, and continues downstream to +1. Two groups of aromatic residues are involved in the initial stages of DNA melting (Figure 4C). First, W256 and W257 forming a chair-like structure interact with base-paired −12T at the upstream edge of the bubble replacing the flipped-out −11A. The second group of aromatic residues Y253, F242, and F248, together with two polar residues R246, E243 form a pocket that captures the flipped-out −11A base. Additionally, in the context of a true promoter, the −11T on the t-strand orphaned by the flipping of −11A, may be stabilized by stacking interaction with another highly conserved aromatic residue Y217 (Bae et al., 2015b). Neither the W256A nor Y217A substitution affected the promoter binding, but rather decreased the rate of RPc → RPo isomerization. Based on this, it is proposed that these residues maintain the ds-ss junction at the upstream edge of the bubble, preventing bubble collapse and RPo dissociation. In another structure of RPo with full bubble DNA and activator protein, R258 (R436) stacks on −12A of t-DNA, facilitating flipping of the t-strand −11 base (Feng et al., 2016). The second canonical nucleotide of the −10 element, −7T of nt-strand, is flipped out and captured in a pocket made of five σ2 and σ1.2 residues: E114, N206, L209, K249, and S251 (Eco E116, N383, R385, L386, S428; Figure 4C), all of which are functionally important (Zhang et al., 2012). Other nucleotides in −10 element make mostly nonspecific contacts with σ2.

Discriminator

The “discriminator” (DSR) region of nt-strand (consensus sequence −6G, −5G, −4G) interacts with eight σ1.2 residues, of which Tth L100 (Eco M102) and Tth H101 (Eco R103) provide the most functionally important contacts (Figure 4D). The purine-rich DSR contributes to the high stability of RPo, whereas pyrimidine-rich sequence in this region destabilizes it (Haugen et al., 2006). This is due to change in the interaction made by the key nucleotides of DSR (−5) with σ; when it is G, it forms and maintains an ordered, stacked conformation of the nt-strand, but when it is C, it flips and is captured by a pocket in σ2, resulting in unstacking and compaction of the downstream ssDNA. Importantly, the presence of C in the middle of DSR in rRNA promoters is also one of the determinants of the transcription start site (TSS) selection (Haugen et al., 2006; Winkelman et al., 2016b). The DSR–σ1.2 interaction is a major determinant of the susceptibility of rRNA and other promoters to negative regulation by ppGpp and DksA (Haugen et al., 2006).

CRE

Nucleotides at positions −3 to +2 on nt-strand constitute “core recognition element” (CRE) that interacts specifically with 10 residues of RNAP β-subunit. Six of these residues form a pocket that captures the flipped-out +2G of CRE at the downstream edge of the bubble, reminiscent of the capturing of flipped-out −11A by σ2. In the pocket, Tth βD326 (Eco D446) makes a hydrogen bond with +2G, which proved to be most critical (Zhang et al., 2012). Adjacent residue Tth βW171 (W183) unstacks the +1T away from the +2G, facilitating its placement into β pocket. In addition to stabilizing and maintaining transcription bubble in RPo, CRE-core interaction affects sequence-specific pausing, and determines TSS selection (Vvedenskaya et al., 2016; Winkelman et al., 2016b). Moreover, it is predicted that CRE-RNAP interactions will affect all stages of transcription where unwound transcription bubble is involved, e.g., slippage, abortive synthesis, promoter escape, factor dependent pausing, termination.

T-strand

A cluster of conserved, positively charged residues of σ2.4 and σ3.0 (Taq R288, and R291, R220) pulls the DNA t-strand from −13 to −10, bending it by 90° through electrostatic interaction with the phosphate backbone, into a groove formed by σ3 linker, β′ lid, and the β′ rudder (Figure 4E; Bae et al., 2015b; Zuo and Steitz, 2015). The t-strand DNA (−9 to −5) is then placed into the main channel between the active site wall, mostly of β, and s3.2 hairpin loop (σ finger), which participates in juxtaposing DNA +1 position to the catalytic center (Figure 4E). Simultaneously, the dsDNA downstream of +3 to +12 is brought inside the downstream DNA binding clamp between the β′ jaw, β lobe-2 and the downstream β′ clamp. The β′ switch-2, a small flexible loop residing in the upstream β′ clamp in the middle of the main channel cavity, controls the binding of the downstream part of the unwound DNA t-strand in the active site cleft. β′ switch-2 functions as a hinge mediating opening and closing of the β′ clamp, and plays a critical role in downstream propagation of transcription bubble during formation of RPo (Mukhopadhyay et al., 2008; Belogurov et al., 2009; Bae et al., 2015b).

Role of σ3.2 finger in RPinit

Recent structural studies showed that during initial transcript synthesis, σ3.2 loop physically occupies the path of nascent RNA and sterically blocks its extension beyond 4~5 nucleotides (Zhang et al., 2012; Basu et al., 2014; Bae et al., 2015b; Zuo and Steitz, 2015). Consistent with its position in the structure of RPo and RPinit, biochemical data show that σ3.2 finger positively affects the binding of the first two initaiting NTPs, abortive RNA synthesis, and promoter escape (Murakami et al., 2002b; Kulbachinskiy and Mustaev, 2006). More recent studies revealed that σ3.2 contributes to promoter opening (Morichaud et al., 2016), suppresses σ-dependent promoter proximal pausing, and accelerates σ dissociation during transition from initiation to elongation (Pupov et al., 2014).

Transcription start site selection (role of DNA scrunching in RPo)

Transcription typically initiates 7 or 8 bp downstream from the −10 element, with a strong bias for purine (R) over pyrimidine (Y) as the initiating nucleotide (+1 position) (Shultzaberger et al., 2007). To identify the determinants for TSS selection, Nickels and coworkers combined a high throughput sequencing (MASTER, “massively systematic transcript end readout”) with multiplexed site-specific RNAP-DNA crosslinking and X-ray structural analyses, to dissect and characterize the role of sequence variation within −6 to +4 positions of the promoter on TSS selection (Winkelman et al., 2016b). The studies identified DSR and CRE as sequence elements that significantly influence TSS selection. G-rich DSR (GGG) and +2G CRE shortens the distance between TSS and −10 element (6-/7-nt from the edge of −10 element), whereas pyrimidine-rich DSR (CCC) and lack of CRE shifts TSS further downstream (8-/9-nt from the edge of −10 element). Disrupting the DSR-σ1.2 and/or CRE-β pocket interactions results in downstream shift of TSS. The changes in TSS correlate with the corresponding shift in the downstream edge of the transcription bubble (in + or − direction), while the upstream edge of the transcription bubble (−10 element) remains constant, demonstrating TSS selection involves transcription-bubble expansion (“scrunching”) and transcription-bubble contraction (“anti-scrunching”; Vvedenskaya et al., 2015; Winkelman et al., 2016b).

Importantly, the unique features of ribosomal promoter sequence (short suboptimal 16 bp spacer, absence of extended −10, and the lack of interactions of DSR/σ1.2, and CRE/β pocket) lead to RPo pre-scrunching and downstream shift of TSS to an unusual position 9 nt from the −10 element. These features reduce abortive synthesis and facilitate promoter escape during initiation, contributing to the high transcriptional activity of rRNA promoters (Winkelman et al., 2016a). At the same time, they destabilize RPo and increase its sensitivity to initiating NTP concentrations, providing a mechanism for rapid down-regulation during starvation.

Besides the TSS region sequences, the negative DNA supercoiling that increases the size of the transcription bubble in RPo also causes downstream shift in the TSS position (Vvedenskaya et al., 2015). These results are consistent with biophysical data correlating bubble expansion with TSS selection (Robb et al., 2013).

Initiation of RNA synthesis

Structures of RPinit were obtained by stabilizing the crystal structures of RPo with RNA oligos complementary to t-strand in the bubble from positions −4 to +1. However, these structures do not reflect the natural state of nascent transcript and DNA during transcription initiation. Recently, more functionally relevant structural data were obtained for RPinit by soaking the crystals of RPo with two initiating substrates, ATP and a non-hydrolyzable anolog of CTP, CMPcPP, occupying i and i+1 sites, respectively. The structure revealed the location of initiating substrate, ATP, in the catalytic center. However, CMPcPP does not occupy the catalytically reactive site since the position of its α-phosphate and the second Mg2+ ion coordinated by its β- and γ-phosphates are too far for catalysis. Also, the trigger helix is partly disordered and does not interact with phosphates of the substrate. Therefore, it is proposed that this structure captures RPinit in a transient state where, i+1 nucleotide is in pre-catalytic conformation (Basu et al., 2014; Zhang et al., 2014; Zuo and Steitz, 2015). De novo synthesis of 6-nt long transcript in crystallo generated a structure of RPinit with RNA-DNA hybrid and the scrunched downstream dsDNA. In the structure, σ3.2 finger is displaced from its position near the active site by the RNA 5′ end, signaling the beginning of σ release from RNAP (Basu et al., 2014).

During scrunching, the pulled-in portions of t- and nt-strands must bulge out of the transcription bubble. Because the X-ray structures of the scrunched ssDNA in RPinit are disordered, their paths have been recently assessed by site-specific DNA-protein crosslinking (Winkelman et al., 2015), exploiting the unusual stability of RPinit formed at ribosomal rrnBP1 promoter (Borukhov et al., 1993). In RPinit containing 5-mer RNA, the nt-strand bulge is extruded through the space between lobe 1 and 2 of β clamp into solvent, whereas the t-strand bulge remains inside the RNAP main channel restricted by the β flap, β lid, β′ clamp, and σ3.2 finger. Mapping results indicate that the t-strand bulge moves toward RNA exit channel, but its exact position is unclear. Extension of RNA beyond 5–6 nt will lead to further bulge expansion resulting in stress build-up, which can be relieved by displacement of σ3.2 finger and/or by opening of the β flap and β′ clamp domains. Further stress accumulation may cause the t-strand bulge to extrude outside either through expansion of the RNA exit channel or through the space opened up between β lobe 1 and σ3. Eventually, the growing 5′ end of nascent RNA will occupy the exit channel displacing σ3 and 4, commencing promoter escape. Another way to relieve the stress caused by t-strand bulge expansion is to reverse the scrunching by releasing the abortive RNA products through the 2°-channel and repeat initiation (Kapanidis et al., 2006; Revyakin et al., 2006).

Activation of Transcription Initiation

Many bacterial promoters contain suboptimal sequences that require binding of specific factors for efficient transcription initiation. Various classes of activators act by facilitating RNAP recruitment to promoters and by accelerating isomerization steps in initiation pathway: RPc → RPi → RPo → RPinit → promoter escape (reviewed in Roy et al., 1998; Lee et al., 2012; Decker and Hinton, 2013). Below, we present two examples of transcription activation systems that have been recently characterized with structural, genetic, and biochemical studies.

Transcription Activation by Class II Initiation Factors: CAP/TAP

Two well-characterized classes of transcriptional activators (class I and II) act through simple RNAP recruitment to promoters with missing or inefficient core promoter elements. Class I activators, exemplified by E. coli CAP (catabolite activator protein) binding at the −61.5 DNA site upstream of the lac promoter, stimulate RPc formation through direct interactions with the RNAP αCTD. Class II activators, such as E. coli CAP binding at the −41.5 site overlapping the −35 element of gal promoter, facilitate formation of RPc and its isomerization into transcriptionally active RPo through multiple contacts (activation regions AR1–AR3) with RNAP αNTD, αCTD, and σ4 domains (Lawson et al., 2004). A structural model of an E. coli class I transcription activation complex of CAP-RPo on a modified lac promoter based on a low resolution electron microscopy data has been generated (Lawson et al., 2004; Hudson et al., 2009) providing information on CAP/DNA, αCTD-DNA, and αCTD-σ4 interactions.

Recently, a 4.4 Å-resolution crystal structure of class II transcription activation complex was reported. It shows Tth activator protein TAP, a homolog of E. coli CAP, in complex with Tth RPo assembled on a TAP-dependent Tth crtB promoter, with a full transcription bubble and a 4 nt-RNA primer (Feng et al., 2016). In the structure, Tth TAP homodimer is bound to DNA at position −41.5 from transcription start site. As expected based on their sequence homology, the structures of Tth TAP-DNA and Eco CAP-DNA are very similar. The structure of RPo is mostly unchanged in TAP-RPo, except that DNA upstream of −35 is slightly distorted by TAP, resulting in reduced interaction between −35 region and σ4. Not surprisingly, biochemical data indicate that specificity of −35 recognition by σ4 does not play a major role in Class II CAP-mediated activation (Rhodius et al., 1997). Yet, intriguingly, mutations of the two σ4 residues (R584, E585) contacting bases at −32 and −33 strongly inhibited RPo formation (Feng et al., 2016). Apparently, the few remaining specific interactions between σ4 and −35 still play an important role in TAP mediated activation.

Role of αCTD in activation

In TAP-RPo structure, the distal subunit of TAP homodimer interacts with one αCTD through an interface that includes ~8 pairs of partnering residues. This interaction (mediated by activation region AR4, a unique feature of TAP) is essential for RPc formation, as demonstrated by the loss of promoter binding following substitutions of AR4/αCTD interface residues. In addition, unlike Eco CAP-RPo, αCTD in TAP-RPo does not interact with DNA. DNA footprinting data show that Tth αCTD does not contribute to DNA binding irrespective of TAP or promoter sequences (Feng et al., 2016), indicating that αCTD is used by TAP only as an RNAP-tether. Indeed, CAP and TAP use different regions to contact αCTD (AR1 and AR4, respectively) that may play a different role in activation. Whereas Eco CAP-AR1/αCTD interaction serves to recruit RNAP to the promoter by DNA-bound CAP, TAP-AR4/αCTD interaction facilitates the association of free RNAP and TAP prior to promoter DNA binding. Because the RNAP-TAP binding constant (6 μM) is comparable to the intracellular RNAP concentration [>5 μM (Patrick et al., 2015)], it is proposed that in addition to classic recruitment pathway, TAP may activate transcription via a pre-recruitment pathway, similar to the mechanism of eukaryotic transcription activation.

The role of TAP-AR2 and -AR3 in activation

TAP-AR2 interacts with β flap domain while TAP-AR3 interacts with σ4 and the β-flap tip helix. Most of these interactions are mediated through polar contacts and salt bridges, and are conserved between Eco CAP and Tth TAP. Mutation of residues in the AR2/β-flap, AR3/β-flap tip, and AR3/σ4 interfaces lead to defects in transcription activation by TAP. Kinetic analysis indicate that similar to CAP (Niu et al., 1996; Rhodius et al., 1997; Rhodius and Busby, 2000), interactions of TAP AR2- and AR3- with RNAP accelerate the transition of RPc to RPo but do not play a significant role in the initial DNA binding (RPc formation).

From the observation that the RPo structure does not change upon interaction with TAP, it is inferred that the mechanism of TAP/CAP Class II activation entails sequential stabilization of intermediate complexes (between RPc and RPo) through simple contacts between ARs and RNAP without inducing any conformational perturbations in RNAP. It should be noted, however, that the reported TAP-RPo structure presents the complex in the final activated state, whereas the path to this state is poorly understood. An alternative to the “activation by adhesion” mechanism can be envisaged which entails allosteric/conformationl changes in the intermediate initiation complexes.

Transcription Activation by RPo Stabilization: CarD

Unlike RNAP of the model organism Eco, RNAPs of many bacteria form intrinsically unstable RPo even at consensus promoters, and require additional factors to stabilize RPo. One such factor is CarD, a global regulator which is an essential factor in Mtb. CarD is widely distributed in at least ten bacterial phyla, including Firmicutes, Cyanobacteria, Actinobacteria, and Deinococcus-Thermus (Bae et al., 2015a), but is absent in γ-Proteobacteria such as Eco. The structure and function of Mtb and Tth CarD have been characterized (Stallings et al., 2009; Gulten and Sacchettini, 2013; Srivastava et al., 2013), and the molecular mechanism of its action was recently proposed based on the 3-D structure of Tth CarD in complex with RPo assembled on consensus promoter DNA with full transcription bubble (Bae et al., 2015a).

CarD consists of N-terminal, RNAP-interacting domain (CarD-RID) and α helical C-terminal domain (CarD-CTD). In CarD-RPo structure, CarD-RID binds RNAP β lobe-1 domain, orienting CarD-CTD toward the upstream ds/ss junction of the transcription bubble near the −10 element. One of the α-helices of CarD-CTD inserts a conserved W86 into the DNA minor groove near positions −12/−13, and acts as a wedge to maintain the distorted conformation of the minor groove immediately upstream of the fork junction. This action is proposed to prevent the reannealing of t- and nt-strands and collapse of transcription bubble, thus stabilizing the RPo. The proposed mechanism of CarD action is strongly supported by the experimental evidence. First, CarD did not affect the conformation of RPo in the structure or alter the size of the transcription bubble during RPo formation on native promoters. Second, kinetic data showed that CarD increased the resistance of RPo to competitor challenge in in vitro assays on native promoters, although it had no effect on RPo assembled on artificial bubble templates (Davis et al., 2015). Finally, mutational analysis indicated that specific interaction between W86 and −12T of nt-strand plays a critical role in RPo stabilization (Bae et al., 2015a). Thus, transcription activation by CarD entails stabilizing the RPo, and prolonging its lifetime sufficient for successful initiation of RNA synthesis.

Analysis of CarD chromosomal distribution using ChipSeq revealed that CarD is associated with RNAP predominantly at promoter regions, co-localizing with σA (Stallings et al., 2009; Srivastava et al., 2013), suggesting that CarD dissociates during early stages of elongation. It's unclear what causes its dissociation. Since the CarD-RID is homologous to the NTD of Mfd, transcription coupled repair factor, which also binds to the β lobe-1, it is possible that CarD is displaced from elongation complex by Mfd. Also, because CarD stabilizes the RPo, it would be expected to negatively affect the rate of promoter escape. Additional biochemical experiments would be needed to address this hypothesis.

Transcription Inhibitors that Target RNAP

Because bacterial RNAP performs essential functions in the cell, and because it differs sufficiently from eukaryotic RNAPs, it is an attractive target for antibiotics (for comprehensive review on the subject, see Ma et al., 2016). Currently, known drugs targeting RNAP can be divided into three groups based on their modes of action (Table 1): (i) those that disrupt RNAP interactions with DNA, RNA or NTPs; (ii) those that interfere with the movement of RNAP mobile elements during nucleotide addition cycle (NAC); and (iii) those that disrupt RNAP interactions with the housekeeping initiation factor, σ70. Although many of these drugs were discovered decades ago, and have been extensively characterized biochemically and genetically since then, it is only with the recent avalanche of structural data obtained for bacterial RNAP in complex many inhibitors that their mechanism of action began to be truly revealed at the molecular level (Murakami, 2015). Below, we summarize briefly the current understanding of how these drugs interact with RNAP from a structural point of view.

www.frontiersin.org

Table 1. Small molecule inhibitors that target RNAP.

The first group comprises inhibitors that bind in the primary channel, the secondary channel, or to the β′ switch-2 region of RNAP. Rifamycins (RIF) and sorangicin bind in the primary channel near the active site, directly contacting β subunit, and sterically block the path of growing RNA beyond 2-3 nucleotides in length, effectively locking the abortive initiation complex at the promoter (Campbell et al., 2001, 2005; Molodtsov et al., 2013). GE23077 binds to the i and i+1 sites of the active center, immediately adjacent to the catalytic Mg2+ ion, and sterically occludes natural substrates from binding to these sites, inhibiting RNAP from initiating transcription de novo (Zhang et al., 2014). Using the structural information and modeling, a bipartite drug that binds to adjoining (but not overlapping) sites near the active center of RNAP was created by covalently linking GE and rifamycin SV (RIF derivative). The resulting compound, RifaGE-3, was active against both RifR and GER RNAPs (Zhang et al., 2014), suggesting that bipartite drugs could represent a new class of antibiotics to combat pathogenic bacteria that are increasingly drug-resistant. However, their large size and complexity may cause reduced permeability and increased cytotoxicity.

Microcin binds in the 2° channel and competitively prevents NTP uptake or binding, thereby inhibiting abortive initiation and elongation (Adelman et al., 2004; Mukhopadhyay et al., 2004). Compounds like myxopyronins, corallopyronin (Mukhopadhyay et al., 2008), ripostatin (Mukhopadhyay et al., 2008; Belogurov et al., 2009), and squaramides (Buurman et al., 2012; Molodtsov et al., 2015) bind to RNAP β′ switch-2 region that controls the hinged, swinging motion of β′ clamp, which in turn is responsible for the opening and closing of the primary channel (Srivastava et al., 2011). Binding of these compounds prevents the β′ clamp from opening, stabilizes the β′ clamp/switch regions in a partly closed/fully closed conformation, and prevents template DNA from reaching the active site. In particular, squaramide, in its co-crystal structure with RNAP, is shown to displace β′ switch-2 into the DNA binding main channel of RNAP (Molodtsov et al., 2015), which would interfere with proper placement of the melted template DNA (Bae et al., 2015b). Fidaxomicin and lipiarmycin (Tupin et al., 2010; Artsimovitch et al., 2012; Morichaud et al., 2016) are structurally closely related natural compounds that also bind to the β′ switch-2 region and prevent t-strand DNA from accessing the RNAP active-site cleft. Interestingly, the sensitivity of RNAP to lipiarmycin is aggravated in the presence of specific mutations in σ70 that are known to destabilize RPo (Morichaud et al., 2016). This result supports the assertion that lipiarmycin, and likely fidoxymicin, competes with t- strand DNA for the same binding site on RNAP β′ switch-2 region during RPo formation, and effectively inhibits promoter melting and RPo formation.

The second group comprises inhibitors that interact with, or bind near the catalytically important mobile elements of RNAP, β′ BH, β′ TL, β-link, and F-loop. These mobile elements are located in the immediate vicinity of the active site of RNAP, and are proposed to undergo conformational changes in concert with NAC (Malinen et al., 2012). Notably, the β′ TL alternates between “open” (unfolded) and “closed” (folded) states, while the adjacent β′ BH alternates between bent and straight conformations (Wang et al., 2006; Jovanovic et al., 2011). These structural changes are thought to accompany each NAC during transcription. In the “closed” conformation, β′ TL forms a three-helix bundle with β′ BH, and is directly contacted by the residues of F-loop and the β-link, which leads to further stabilization of the folded conformation of the β′ TL. NTP loading and catalysis occur in this state. In the “open” conformation, the three-helix bundle collapses: β′ BH bends toward RNA–DNA hybrid; β′ TL becomes unfolded. This state presumably permits RNA and DNA translocation following catalysis. Streptolydigin (Temiakov et al., 2005; Tuske et al., 2005; Vassylyev et al., 2007), salinamide (Degen et al., 2014), CBR (Artsimovitch et al., 2003, 2011; Malinen et al., 2012, 2014; Yuzenkova et al., 2013; Bae et al., 2015c; Feng et al., 2015), and, most likely targetitoxin (Artsimovitch et al., 2011; Malinen et al., 2012; Yuzenkova et al., 2013), are all inhibitors that bind RNAP and interact intimately with non-overlapping residues of β′ BH, β′ TL, β′ F-loop, and/or β-link in the active site milieu. Extensive structural and biochemical studies support the mechanistic model that these inhibitors stabilize an intermediate complex formed during NAC by immobilizing one or more mobile elements in a fixed conformation, thereby halting the iterative catalytic process. Binding sites of salinamide and CBR on Eco RNAP identified from analysis of X-ray co-crystal structures are consistent with their genetically-mapped binding sites. Interestingly, it was reported that two CBRR mutations, P750 → L in β′ F-loop and F773 → V in β′ BH N-terminus, also conferred CBR dependence for cell growth (Bae et al., 2015c). One possible explanation for this observation is that the mutations made these mobile elements too flexible to support NAC, and that binding of CBR compensated for this defect. This interpretation would be consistent with the proposed mechanism of action of CBR.

The third group of inhibitors include compounds of GKL-, DSHS-, and SB-series, all derived from chemical compound libraries, that are predicted to directly inhibit RNAP-σ70 interaction. The SB-series compounds were discovered by screening the library using ELISA-based assay, and while they inhibited RNAP-σ70 association with IC50 ranging from 2 to 15 μM, many showed nonspecific binding to unrelated targets in vivo (André et al., 2004, 2006). GKL- and DSHS-series were screened in silico based on the strategy of structure-based drug design, and subsequently tested in vitro for validation (Ma et al., 2013; Yang et al., 2015a). As predicted by pharmacophore modeling, select compounds of GKL- and DSHS-series were shown to compete with σ70 for binding to RNAP core to form holoenzyme. More analysis and characterization is required to determine if these compounds can be further developed as potential antibacterial drugs. In theory, it should be possible to screen for compounds that inhibit σ dissociation from RPo using the same pharmacophore model (Ma et al., 2013), or one based on the RPo complex structure. An attractive target interface for such an inhibitor would be the RNA exit channel, where blocking of σ3.2 release would cause essentially the same inhibitory effect as RIF.

A survey of currently available RNAP-specific inhibitors reveals that for many lead compounds, the predicted in vivo effectiveness is often low due to their poor permeability, cytotoxicity, and broad resistance spectrum. Therefore, future drug designs will need to include strategies for incorporating effective delivery mechanisms, such as nanoparticles or functional conjugates that can be cleaved/unloaded inside the cell. Design for new drugs should also aim to improve solubility and reduce nonspecific, aggregate-forming properties of drugs associated with cytotoxicity. The construction of bipartite molecules, in principle, offers a highly promising approach to achieve increased potency and low resistance spectrum. It remains to be seen if, with the right combination of linked inhibitors and modifications, an effective bipartite drug can be constructed that is permeable with negligible toxicity. Finally, to design inhibitors of RNAP with narrow resistance spectrum, it is instructive to note that Sorangicin, which resembles RIF and binds to the same site on RNAP, exhibits a narrower resistance spectrum than RIF. This is attributed to its presumed greater conformational flexibility, enabling it to accommodate mutations in the RIF-binding pocket (Campbell et al., 2005). This suggests that a built-in structural flexibility of the compound may be an important factor in smart drug design.

Concluding Remarks

The last 15 years saw a remarkable progress in our understanding of the structure-function relationship of bacterial RNAP thanks to the advances in structural studies of this enzyme. It is hoped that in the near future, structural studies will continue to reveal fine details of transcription, especially of the events during formation of RPc, scrunching of RPinit and termination processes. Additionally, an exciting new direction in RNAP research is emerging with the advent of high throughput sequencing and screening techniques, which will help to shed new light on the function of RNAP in the context of true physiological environment.

Author Contributions

JL and SB equally contributed to the preparation and writing of the manuscript.

Funding

Research in SB lab is supported by the Department of Cell Biology and the Graduate School of Biomedical Studies at Rowan University.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

Authors are grateful to our colleagues R. Gourse, E. Nudler, A. Kulbachinskiy, and M. Cashel for helpful discussions and advices. We apologize to those researchers whose work has not been cited due to space limitations.

References

Adelman, K., Yuzenkova, J., La Porta, A., Zenkin, N., Lee, J., Lis, J. T., et al. (2004). Molecular mechanism of transcription inhibition by peptide antibiotic Microcin J25. Mol. Cell 14, 753–762. doi: 10.1016/j.molcel.2004.05.017

PubMed Abstract | CrossRef Full Text | Google Scholar

André, E., Bastide, L., Michaux-Charachon, S., Gouby, A., Villain-Guillot, P., Latouche, J., et al. (2006). Novel synthetic molecules targeting the bacterial RNA polymerase assembly. J. Antimicrob. Chemother. 57, 245–251. doi: 10.1093/jac/dki426

PubMed Abstract | CrossRef Full Text | Google Scholar

André, E., Bastide, L., Villain-Guillot, P., Latouche, J., Rouby, J., and Leonetti, J. P. (2004). A multiwell assay to isolate compounds inhibiting the assembly of the prokaryotic RNA polymerase. Assay Drug Dev. Technol. 2, 629–635. doi: 10.1089/adt.2004.2.629

PubMed Abstract | CrossRef Full Text | Google Scholar

Artsimovitch, I., Chu, C., Lynch, A. S., and Landick, R. (2003). A new class of bacterial RNA polymerase inhibitor affects nucleotide addition. Science 302, 650–654. doi: 10.1126/science.1087526

PubMed Abstract | CrossRef Full Text | Google Scholar

Artsimovitch, I., Seddon, J., and Sears, P. (2012). Fidaxomicin is an inhibitor of the initiation of bacterial RNA synthesis. Clin. Infect. Dis. 55(Suppl. 2), S127–S131. doi: 10.1093/cid/cis358

PubMed Abstract | CrossRef Full Text | Google Scholar

Artsimovitch, I., Svetlov, V., Nemetski, S. M., Epshtein, V., Cardozo, T., and Nudler, E. (2011). Tagetitoxin inhibits RNA polymerase through trapping of the trigger loop. J. Biol. Chem. 286, 40395–40400. doi: 10.1074/jbc.M111.300889

PubMed Abstract | CrossRef Full Text | Google Scholar

Bae, B., Chen, J., Davis, E., Leon, K., Darst, S. A., and Campbell, E. A. (2015a). CarD uses a minor groove wedge mechanism to stabilize the RNA polymerase open promoter complex. Elife 4:e08505. doi: 10.7554/eLife.08505

PubMed Abstract | CrossRef Full Text | Google Scholar

Bae, B., Davis, E., Brown, D., Campbell, E. A., Wigneshweraraj, S., and Darst, S. A. (2013). Phage T7 Gp2 inhibition of Escherichia coli RNA polymerase involves misappropriation of sigma70 domain 1.1. Proc. Natl. Acad. Sci. U.S.A. 110, 19772–19777. doi: 10.1073/pnas.1314576110

PubMed Abstract | CrossRef Full Text | Google Scholar

Bae, B., Feklistov, A., Lass-Napiorkowska, A., Landick, R., and Darst, S. A. (2015b). Structure of a bacterial RNA polymerase holoenzyme open promoter complex. Elife 4:e08504. doi: 10.7554/eLife.08504

PubMed Abstract | CrossRef Full Text | Google Scholar

Bae, B., Nayak, D., Ray, A., Mustaev, A., Landick, R., and Darst, S. A. (2015c). CBR antimicrobials inhibit RNA polymerase via at least two bridge-helix cap-mediated effects on nucleotide addition. Proc. Natl. Acad. Sci. U.S.A. 112, E4178–E4187. doi: 10.1073/pnas.1502368112

PubMed Abstract | CrossRef Full Text | Google Scholar

Basu, R. S., Warner, B. A., Molodtsov, V., Pupov, D., Esyunina, D., Fernández-Tornero, C., et al. (2014). Structural basis of transcription initiation by bacterial RNA polymerase holoenzyme. J. Biol. Chem. 289, 24549–24559. doi: 10.1074/jbc.M114.584037

PubMed Abstract | CrossRef Full Text | Google Scholar

Belogurov, G. A., Vassylyeva, M. N., Sevostyanova, A., Appleman, J. R., Xiang, A. X., Lira, R., et al. (2009). Transcription inactivation through local refolding of the RNA polymerase structure. Nature 457, 332–335. doi: 10.1038/nature07510

PubMed Abstract | CrossRef Full Text | Google Scholar

Benoff, B., Yang, H., Lawson, C. L., Parkinson, G., Liu, J., Blatter, E., et al. (2002). Structural basis of transcription activation: the CAP-alpha CTD-DNA complex. Science 297, 1562–1566. doi: 10.1126/science.1076376

PubMed Abstract | CrossRef Full Text | Google Scholar

Borukhov, S., and Nudler, E. (2003). RNA polymerase holoenzyme: structure, function and biological implications. Curr. Opin. Microbiol. 6, 93–100. doi: 10.1016/S1369-5274(03)00036-5

PubMed Abstract | CrossRef Full Text | Google Scholar

Borukhov, S., Sagitov, V., Josaitis, C. A., Gourse, R. L., and Goldfarb, A. (1993). Two modes of transcription initiation in vitro at the rrnB P1 promoter of Escherichia coli. J. Biol. Chem. 268, 23477–23482.

PubMed Abstract | Google Scholar

Buurman, E. T., Foulk, M. A., Gao, N., Laganas, V. A., McKinney, D. C., Moustakas, D. T., et al. (2012). Novel rapidly diversifiable antimicrobial RNA polymerase switch region inhibitors with confirmed mode of action in Haemophilus influenzae. J. Bacteriol. 194, 5504–5512. doi: 10.1128/JB.01103-12

PubMed Abstract | CrossRef Full Text | Google Scholar

Campbell, E. A., Korzheva, N., Mustaev, A., Murakami, K., Nair, S., Goldfarb, A., et al. (2001). Structural mechanism for rifampicin inhibition of bacterial rna polymerase. Cell 104, 901–912. doi: 10.1016/S0092-8674(01)00286-0

PubMed Abstract | CrossRef Full Text | Google Scholar

Campbell, E. A., Muzzin, O., Chlenov, M., Sun, J. L., Olson, C. A., Weinman, O., et al. (2002). Structure of the bacterial RNA polymerase promoter specificity sigma subunit. Mol. Cell 9, 527–539. doi: 10.1016/S1097-2765(02)00470-7

PubMed Abstract | CrossRef Full Text | Google Scholar

Campbell, E. A., Pavlova, O., Zenkin, N., Leon, F., Irschik, H., Jansen, R., et al. (2005). Structural, functional, and genetic analysis of sorangicin inhibition of bacterial RNA polymerase. EMBO J. 24, 674–682. doi: 10.1038/sj.emboj.7600499

PubMed Abstract | CrossRef Full Text | Google Scholar

Chen, Y. F., and Helmann, J. D. (1997). DNA-melting at the Bacillus subtilis flagellin promoter nucleates near -10 and expands unidirectionally. J. Mol. Biol. 267, 47–59. doi: 10.1006/jmbi.1996.0853

PubMed Abstract | CrossRef Full Text | Google Scholar

Daniels, D., Zuber, P., and Losick, R. (1990). Two amino acids in an RNA polymerase sigma factor involved in the recognition of adjacent base pairs in the -10 region of a cognate promoter. Proc. Natl. Acad. Sci. U.S.A. 87, 8075–8079. doi: 10.1073/pnas.87.20.8075

PubMed Abstract | CrossRef Full Text | Google Scholar

Davis, E., Chen, J., Leon, K., Darst, S. A., and Campbell, E. A. (2015). Mycobacterial RNA polymerase forms unstable open promoter complexes that are stabilized by CarD. Nucleic Acids Res. 43, 433–445. doi: 10.1093/nar/gku1231

PubMed Abstract | CrossRef Full Text | Google Scholar

Decker, K. B., and Hinton, D. M. (2013). Transcription regulation at the core: similarities among bacterial, archaeal, and eukaryotic RNA polymerases. Annu. Rev. Microbiol. 67, 113–139. doi: 10.1146/annurev-micro-092412-155756

PubMed Abstract | CrossRef Full Text | Google Scholar

Degen, D., Feng, Y., Zhang, Y., Ebright, K. Y., Ebright, Y. W., Gigliotti, M., et al. (2014). Transcription inhibition by the depsipeptide antibiotic salinamide A. Elife 3:e02451. doi: 10.7554/eLife.02451

PubMed Abstract | CrossRef Full Text | Google Scholar

Feklistov, A., Barinova, N., Sevostyanova, A., Heyduk, E., Bass, I., Vvedenskaya, I., et al. (2006). A basal promoter element recognized by free RNA polymerase sigma subunit determines promoter recognition by RNA polymerase holoenzyme. Mol. Cell 23, 97–107. doi: 10.1016/j.molcel.2006.06.010

PubMed Abstract | CrossRef Full Text | Google Scholar

Feklistov, A., and Darst, S. A. (2011). Structural basis for promoter-10 element recognition by the bacterial RNA polymerase sigma subunit. Cell 147, 1257–1269. doi: 10.1016/j.cell.2011.10.041

PubMed Abstract | CrossRef Full Text | Google Scholar

Feklístov, A., Sharon, B. D., Darst, S. A., and Gross, C. A. (2014). Bacterial sigma factors: a historical, structural, and genomic perspective. Annu. Rev. Microbiol. 68, 357–376. doi: 10.1146/annurev-micro-092412-155737

PubMed Abstract | CrossRef Full Text | Google Scholar

Feng, Y., Degen, D., Wang, X., Gigliotti, M., Liu, S., Zhang, Y., et al. (2015). tructural Basis of Transcription Inhibition by CBR Hydroxamidines and CBR Pyrazoles. Structure 23, 1470–1481. doi: 10.1016/j.str.2015.06.009

PubMed Abstract | CrossRef Full Text | Google Scholar

Goldman, S. R., Nair, N. U., Wells, C. D., Nickels, B. E., and Hochschild, A. (2015). The primary sigma factor in Escherichia coli can access the transcription elongation complex from solution in vivo. Elife 4:e10514. doi: 10.7554/eLife.10514

PubMed Abstract | CrossRef Full Text | Google Scholar

Gruber, T. M., and Gross, C. A. (2003). Multiple sigma subunits and the partitioning of bacterial transcription space. Annu. Rev. Microbiol. 57, 441–466. doi: 10.1146/annurev.micro.57.030502.090913

PubMed Abstract | CrossRef Full Text | Google Scholar

Gruber, T. M., Markov, D., Sharp, M. M., Young, B. A., Lu, C. Z., Zhong, H. J., et al. (2001). Binding of the initiation factor sigma to core RNA polymerase is a multistep process. Mol. Cell 8, 21–31. doi: 10.1016/S1097-2765(01)00292-1

PubMed Abstract | CrossRef Full Text | Google Scholar

Gulten, G., and Sacchettini, J. C. (2013). Structure of the Mtb CarD/RNAP beta-lobes complex reveals the molecular basis of interaction and presents a distinct DNA-binding domain for Mtb CarD. Structure 21, 1859–1869. doi: 10.1016/j.str.2013.08.014

PubMed Abstract | CrossRef Full Text | Google Scholar

Haugen, S. P., Berkmen, M. B., Ross, W., Gaal, T., Ward, C., and Gourse, R. L. (2006). rRNA promoter regulation by nonoptimal binding of sigma region 1.2: an additional recognition element for RNA polymerase. Cell 125, 1069–1082. doi: 10.1016/j.cell.2006.04.034

PubMed Abstract | CrossRef Full Text | Google Scholar

Haugen, S. P., Ross, W., and Gourse, R. L. (2008). Advances in bacterial promoter recognition and its control by factors that do not bind DNA. Nat. Rev. Microbiol. 6, 507–519. doi: 10.1038/nrmicro1912

PubMed Abstract | CrossRef Full Text | Google Scholar

Hook-Barnard, I. G., and Hinton, D. M. (2007). Transcription initiation by mix and match elements: flexibility for polymerase binding to bacterial promoters. Gene Regul. Syst. Bio. 1, 275–293.

PubMed Abstract | Google Scholar

Hudson, B. P., Quispe, J., Lara-González, S., Kim, Y., Berman, H. M., Arnold, E., et al. (2009). Three-dimensional EM structure of an intact activator-dependent transcription initiation complex. Proc. Natl. Acad. Sci. U.S.A. 106, 19830–19835. doi: 10.1073/pnas.0908782106

PubMed Abstract | CrossRef Full Text | Google Scholar

Imashimizu, M., Shimamoto, N., Oshima, T., and Kashlev, M. (2014). Transcription elongation: heterogeneous tracking of RNA polymerase and its biological implications. Transcription 5:e28285. doi: 10.4161/trns.28285

PubMed Abstract | CrossRef Full Text | Google Scholar

Jovanovic, M., Burrows, P. C., Bose, D., Cámara, B., Wiesler, S., Zhang, X., et al. (2011). Activity map of the Escherichia coli RNA polymerase bridge helix. J. Biol. Chem. 286, 14469–14479. doi: 10.1074/jbc.M110.212902

PubMed Abstract | CrossRef Full Text | Google Scholar

Kamarthapu, V., Epshtein, V., Benjamin, B., Proshkin, S., Mironov, A., Cashel, M., et al. (2016). ppGpp couples transcription to DNA repair in E. coli. Science 352, 993–996. doi: 10.1126/science.aad6945

PubMed Abstract | CrossRef Full Text | Google Scholar

Kapanidis, A. N., Margeat, E., Ho, S. O., Kortkhonjia, E., Weiss, S., and Ebright, R. H. (2006). Initial transcription by RNA polymerase proceeds through a DNA-scrunching mechanism. Science 314, 1144–1147. doi: 10.1126/science.1131399

PubMed Abstract | CrossRef Full Text | Google Scholar

Keilty, S., and Rosenberg, M. (1987). Constitutive function of a positively regulated promoter reveals new sequences essential for activity. J. Biol. Chem. 262, 6389–6395.

PubMed Abstract | Google Scholar

Kriner, M. A., Sevostyanova, A., and Groisman, E. A. (2016). Learning from the Leaders: gene regulation by the transcription termination factor Rho. Trends Biochem. Sci. 41, 690–699. doi: 10.1016/j.tibs.2016.05.012

PubMed Abstract | CrossRef Full Text | Google Scholar

Kulbachinskiy, A., and Mustaev, A. (2006). Region 3.2 of the sigma subunit contributes to the binding of the 3′-initiating nucleotide in the RNA polymerase active center and facilitates promoter clearance during initiation. J. Biol. Chem. 281, 18273–18276. doi: 10.1074/jbc.C600060200

PubMed Abstract | CrossRef Full Text | Google Scholar

Lawson, C. L., Swigon, D., Murakami, K. S., Darst, S. A., Berman, H. M., and Ebright, R. H. (2004). Catabolite activator protein: DNA binding and transcription activation. Curr. Opin. Struct. Biol. 14, 10–20. doi: 10.1016/j.sbi.2004.01.012

PubMed Abstract | CrossRef Full Text | Google Scholar

Lim, H. M., Lee, H. J., Roy, S., and Adhya, S. (2001). A “master” in base unpairing during isomerization of a promoter upon RNA polymerase binding. Proc. Natl. Acad. Sci. U.S.A. 98, 14849–14852. doi: 10.1073/pnas.261517398

PubMed Abstract | CrossRef Full Text | Google Scholar

Liu, B., Zuo, Y., and Steitz, T. A. (2015). Structural basis for transcription reactivation by RapA. Proc. Natl. Acad. Sci. U.S.A. 112, 2006–2010. doi: 10.1073/pnas.1417152112

PubMed Abstract | CrossRef Full Text | Google Scholar

Liu, B., Zuo, Y., and Steitz, T. A. (2016). Structures of E. coli sigmaS-transcription initiation complexes provide new insights into polymerase mechanism. Proc. Natl. Acad. Sci. U.S.A. 113, 4051–4056. doi: 10.1073/pnas.1520555113

PubMed Abstract | CrossRef Full Text | Google Scholar

Liu, M., Tolstorukov, M., Zhurkin, V., Garges, S., and Adhya, S. (2004). A mutant spacer sequence between −35 and −10 elements makes the Plac promoter hyperactive and cAMP receptor protein-independent. Proc. Natl. Acad. Sci. U.S.A. 101, 6911–6916. doi: 10.1073/pnas.0401929101

PubMed Abstract | CrossRef Full Text | Google Scholar

Ma, C., Yang, X., Kandemir, H., Mielczarek, M., Johnston, E. B., Griffith, R., et al. (2013). Inhibitors of bacterial transcription initiation complex formation. ACS Chem. Biol. 8, 1972–1980. doi: 10.1021/cb400231p

PubMed Abstract | CrossRef Full Text | Google Scholar

Ma, C., Yang, X., and Lewis, P. J. (2016). Bacterial transcription as a target for antibacterial drug development. Microbiol. Mol. Biol. Rev. 80, 139–160. doi: 10.1128/MMBR.00055-15

PubMed Abstract | CrossRef Full Text | Google Scholar

Maeda, H., Fujita, N., and Ishihama, A. (2000). Competition among seven Escherichia coli sigma subunits: relative binding affinities to the core RNA polymerase. Nucleic Acids Res. 28, 3497–3503. doi: 10.1093/nar/28.18.3497

PubMed Abstract | CrossRef Full Text | Google Scholar

Malinen, A. M., Nandymazumdar, M., Turtola, M., Malmi, H., Grocholski, T., Artsimovitch, I., et al. (2014). CBR antimicrobials alter coupling between the bridge helix and the beta subunit in RNA polymerase. Nat. Commun. 5, 3408. doi: 10.1038/ncomms4408

PubMed Abstract | CrossRef Full Text | Google Scholar

Malinen, A. M., Turtola, M., Parthiban, M., Vainonen, L., Johnson, M. S., and Belogurov, G. A. (2012). Active site opening and closure control translocation of multisubunit RNA polymerase. Nucleic Acids Res. 40, 7442–7451. doi: 10.1093/nar/gks383

PubMed Abstract | CrossRef Full Text | Google Scholar

Mekler, V., Kortkhonjia, E., Mukhopadhyay, J., Knight, J., Revyakin, A., Kapanidis, A. N., et al. (2002). Structural organization of bacterial RNA polymerase holoenzyme and the RNA polymerase-promoter open complex. Cell 108, 599–614. doi: 10.1016/S0092-8674(02)00667-0

PubMed Abstract | CrossRef Full Text | Google Scholar

Molodtsov, V., Fleming, P. R., Eyermann, C. J., Ferguson, A. D., Foulk, M. A., McKinney, D. C., et al. (2015). X-ray crystal structures of Escherichia coli RNA polymerase with switch region binding inhibitors enable rational design of squaramides with an improved fraction unbound to human plasma protein. J. Med. Chem. 58, 3156–3171. doi: 10.1021/acs.jmedchem.5b00050

PubMed Abstract | CrossRef Full Text | Google Scholar

Molodtsov, V., Nawarathne, I. N., Scharf, N. T., Kirchhoff, P. D., Showalter, H. D., Garcia, G. A., et al. (2013). X-ray crystal structures of the Escherichia coli RNA polymerase in complex with benzoxazinorifamycins. J. Med. Chem. 56, 4758–4763. doi: 10.1021/jm4004889

PubMed Abstract | CrossRef Full Text | Google Scholar

Morichaud, Z., Chaloin, L., and Brodolin, K. (2016). Regions 1.2 and 3.2 of the RNA Polymerase sigma subunit promote DNA melting and attenuate action of the antibiotic lipiarmycin. J. Mol. Biol. 428, 463–476. doi: 10.1016/j.jmb.2015.12.017

PubMed Abstract | CrossRef Full Text | Google Scholar

Mukhopadhyay, J., Das, K., Ismail, S., Koppstein, D., Jang, M., Hudson, B., et al. (2008). The RNA polymerase “switch region” is a target for inhibitors. Cell 135, 295–307. doi: 10.1016/j.cell.2008.09.033

PubMed Abstract | CrossRef Full Text | Google Scholar

Mukhopadhyay, J., Sineva, E., Knight, J., Levy, R. M., and Ebright, R. H. (2004). Antibacterial peptide microcin J25 inhibits transcription by binding within and obstructing the RNA polymerase secondary channel. Mol. Cell 14, 739–751. doi: 10.1016/j.molcel.2004.06.010

PubMed Abstract | CrossRef Full Text | Google Scholar

Murakami, K. S., Masuda, S., Campbell, E. A., Muzzin, O., and Darst, S. A. (2002a). Structural basis of transcription initiation: an RNA polymerase holoenzyme-DNA complex. Science 296, 1285–1290. doi: 10.1126/science.1069595

PubMed Abstract | CrossRef Full Text | Google Scholar

Murakami, K. S., Masuda, S., and Darst, S. A. (2002b). Structural basis of transcription initiation: RNA polymerase holoenzyme at 4 A resolution. Science 296, 1280–1284. doi: 10.1126/science.1069594

PubMed Abstract | CrossRef Full Text | Google Scholar

Niu, W., Kim, Y., Tau, G., Heyduk, T., and Ebright, R. H. (1996). Transcription activation at class II CAP-dependent promoters: two interactions between CAP and RNA polymerase. Cell 87, 1123–1134. doi: 10.1016/S0092-8674(00)81806-1

PubMed Abstract | CrossRef Full Text | Google Scholar

Pupov, D., Kuzin, I., Bass, I., and Kulbachinskiy, A. (2014). Distinct functions of the RNA polymerase sigma subunit region 3.2 in RNA priming and promoter escape. Nucleic Acids Res. 42, 4494–4504. doi: 10.1093/nar/gkt1384

PubMed Abstract | CrossRef Full Text | Google Scholar

Revyakin, A., Liu, C., Ebright, R. H., and Strick, T. R. (2006). Abortive initiation and productive initiation by RNA polymerase involve DNA scrunching. Science 314, 1139–1143. doi: 10.1126/science.1131398

PubMed Abstract | CrossRef Full Text | Google Scholar

Rhodius, V. A., and Busby, S. J. (2000). Transcription activation by the Escherichia coli cyclic AMP receptor protein: determinants within activating region 3. J. Mol. Biol. 299, 295–310. doi: 10.1006/jmbi.2000.3736

PubMed Abstract | CrossRef Full Text | Google Scholar

Rhodius, V. A., West, D. M., Webster, C. L., Busby, S. J., and Savery, N. J. (1997). Transcription activation at class II CRP-dependent promoters: the role of different activating regions. Nucleic Acids Res. 25, 326–332. doi: 10.1093/nar/25.2.326

PubMed Abstract | CrossRef Full Text | Google Scholar

Robb, N. C., Cordes, T., Hwang, L. C., Gryte, K., Duchi, D., Craggs, T. D., et al. (2013). The transcription bubble of the RNA polymerase-promoter open complex exhibits conformational heterogeneity and millisecond-scale dynamics: implications for transcription start-site selection. J. Mol. Biol. 425, 875–885. doi: 10.1016/j.jmb.2012.12.015

PubMed Abstract | CrossRef Full Text | Google Scholar

Roberts, J., and Park, J. S. (2004). Mfd, the bacterial transcription repair coupling factor: translocation, repair and termination. Curr. Opin. Microbiol. 7, 120–125. doi: 10.1016/j.mib.2004.02.014

PubMed Abstract | CrossRef Full Text | Google Scholar

Ross, W., Ernst, A., and Gourse, R. L. (2001). Fine structure of E. coli RNA polymerase-promoter interactions: alpha subunit binding to the UP element minor groove. Genes Dev. 15, 491–506. doi: 10.1101/gad.870001

PubMed Abstract | CrossRef Full Text

Ross, W., Gosink, K. K., Salomon, J., Igarashi, K., Zou, C., Ishihama, A., et al. (1993). A third recognition element in bacterial promoters: DNA binding by the alpha subunit of RNA polymerase. Science 262, 1407–1413. doi: 10.1126/science.8248780

PubMed Abstract | CrossRef Full Text | Google Scholar

Roy, S., Garges, S., and Adhya, S. (1998). Activation and repression of transcription by differential contact: two sides of a coin. J. Biol. Chem. 273, 14059–14062. doi: 10.1074/jbc.273.23.14059

PubMed Abstract | CrossRef Full Text | Google Scholar

Saecker, R. M., Record, M. T. Jr., and Dehaseth, P. L. (2011). Mechanism of bacterial transcription initiation: RNA polymerase - promoter binding, isomerization to initiation-competent open complexes, and initiation of RNA synthesis. J. Mol. Biol. 412, 754–771. doi: 10.1016/j.jmb.2011.01.018

PubMed Abstract | CrossRef Full Text | Google Scholar

Samanta, S., and Martin, C. T. (2013). Insights into the mechanism of initial transcription in Escherichia coli RNA polymerase. J. Biol. Chem. 288, 31993–32003. doi: 10.1074/jbc.M113.497669

PubMed Abstract | CrossRef Full Text | Google Scholar

Sarkar, P., Sardesai, A. A., Murakami, K. S., and Chatterji, D. (2013). Inactivation of the bacterial RNA polymerase due to acquisition of secondary structure by the omega subunit. J. Biol. Chem. 288, 25076–25087. doi: 10.1074/jbc.M113.468520

PubMed Abstract | CrossRef Full Text | Google Scholar

Sen, R., Nagai, H., Hernandez, V. J., and Shimamoto, N. (1998). Reduction in abortive transcription from the lambdaPR promoter by mutations in region 3 of the sigma70 subunit of Escherichia coli RNA polymerase. J. Biol. Chem. 273, 9872–9877. doi: 10.1074/jbc.273.16.9872

PubMed Abstract | CrossRef Full Text | Google Scholar

Sengupta, S., Prajapati, R. K., and Mukhopadhyay, J. (2015). Promoter Escape with bacterial two-component sigma factor suggests retention of sigma region two in the elongation complex. J. Biol. Chem. 290, 28575–28583. doi: 10.1074/jbc.M115.666008

PubMed Abstract | CrossRef Full Text | Google Scholar

Sharp, M. M., Chan, C. L., Lu, C. Z., Marr, M. T., Nechaev, S., Merritt, E. W., et al. (1999). The interface of sigma with core RNA polymerase is extensive, conserved, and functionally specialized. Genes Dev. 13, 3015–3026. doi: 10.1101/gad.13.22.3015

PubMed Abstract | CrossRef Full Text | Google Scholar

Shorenstein, R. G., and Losick, R. (1973). Purification and properties of the sigma subunit of ribonucleic acid polymerase from vegetative Bacillus subtilis. J. Biol. Chem. 248, 6163–6169.

PubMed Abstract | Google Scholar

Shultzaberger, R. K., Chen, Z., Lewis, K. A., and Schneider, T. D. (2007). Anatomy of Escherichia coli sigma70 promoters. Nucleic Acids Res. 35, 771–788. doi: 10.1093/nar/gkl956

PubMed Abstract | CrossRef Full Text | Google Scholar

Srivastava, A., Talaue, M., Liu, S., Degen, D., Ebright, R. Y., Sineva, E., et al. (2011). New target for inhibition of bacterial RNA polymerase: ‘switch region.’ Curr. Opin. Microbiol. 14, 532–543. doi: 10.1016/j.mib.2011.07.030

PubMed Abstract | CrossRef Full Text | Google Scholar

Srivastava, D. B., Leon, K., Osmundson, J., Garner, A. L., Weiss, L. A., Westblade, L. F., et al. (2013). Structure and function of CarD, an essential mycobacterial transcription factor. Proc. Natl. Acad. Sci. U.S.A. 110, 12619–12624. doi: 10.1073/pnas.1308270110

PubMed Abstract | CrossRef Full Text | Google Scholar

Stallings, C. L., Stephanou, N. C., Chu, L., Hochschild, A., Nickels, B. E., and Glickman, M. S. (2009). CarD is an essential regulator of rRNA transcription required for Mycobacterium tuberculosis persistence. Cell 138, 146–159. doi: 10.1016/j.cell.2009.04.041

PubMed Abstract | CrossRef Full Text | Google Scholar

Temiakov, D., Zenkin, N., Vassylyeva, M. N., Perederina, A., Tahirov, T. H., Kashkina, E., et al. (2005). Structural basis of transcription inhibition by antibiotic streptolydigin. Mol. Cell 19, 655–666. doi: 10.1016/j.molcel.2005.07.020

PubMed Abstract | CrossRef Full Text | Google Scholar

Tupin, A., Gualtieri, M., Leonetti, J. P., and Brodolin, K. (2010). The transcription inhibitor lipiarmycin blocks DNA fitting into the RNA polymerase catalytic site. EMBO J. 29, 2527–2537. doi: 10.1038/emboj.2010.135

PubMed Abstract | CrossRef Full Text | Google Scholar

Tuske, S., Sarafianos, S. G., Wang, X., Hudson, B., Sineva, E., Mukhopadhyay, J., et al. (2005). Inhibition of bacterial RNA polymerase by streptolydigin: stabilization of a straight-bridge-helix active-center conformation. Cell 122, 541–552. doi: 10.1016/j.cell.2005.07.017

PubMed Abstract | CrossRef Full Text | Google Scholar

Vassylyev, D. G., Sekine, S., Laptenko, O., Lee, J., Vassylyeva, M. N., Borukhov, S., et al. (2002). Crystal structure of a bacterial RNA polymerase holoenzyme at 2.6 A resolution. Nature 417, 712–719. doi: 10.1038/nature752

PubMed Abstract | CrossRef Full Text | Google Scholar

Vassylyev, D. G., Vassylyeva, M. N., Zhang, J., Palangat, M., Artsimovitch, I., and Landick, R. (2007). Structural basis for substrate loading in bacterial RNA polymerase. Nature 448, 163–168. doi: 10.1038/nature05931

PubMed Abstract | CrossRef Full Text | Google Scholar

Vvedenskaya, I. O., Vahedian-Movahed, H., Zhang, Y., Taylor, D. M., Ebright, R. H., and Nickels, B. E. (2016). Interactions between RNA polymerase and the core recognition element are a determinant of transcription start site selection. Proc. Natl. Acad. Sci. U.S.A. 113, E2899–E2905. doi: 10.1073/pnas.1603271113

PubMed Abstract | CrossRef Full Text | Google Scholar

Vvedenskaya, I. O., Zhang, Y., Goldman, S. R., Valenti, A., Visone, V., Taylor, D. M., et al. (2015). Massively systematic transcript end readout, “MASTER”: transcription start site selection, transcriptional slippage, and transcript yields. Mol. Cell 60, 953–965. doi: 10.1016/j.molcel.2015.10.029

PubMed Abstract | CrossRef Full Text

Sours: https://www.frontiersin.org/articles/10.3389/fmolb.2016.00073/full
  1. Century 21 jackson hole
  2. Bath apartments short stay
  3. Ebay postcards for sale
  4. Travel trailers chattanooga tn

RNA polymerase

Compare RNA-dependent RNA polymerase.

RNA polymerase (purple) unwinding the DNA double helix and uses one strand (darker orange) as a template to create the single-stranded messenger RNA (green)

In molecular biology, RNA polymerase (abbreviated RNAP or RNApol, and officially DNA-directed (dependent) RNA polymerase), is an enzyme that synthesizes RNA from a DNA template.

Using the enzyme helicase, RNAP locally opens the double-stranded DNA so that one strand of the exposed nucleotides can be used as a template for the synthesis of RNA, a process called transcription. A transcription factor and its associated transcription mediator complex must be attached to a DNA binding site called a promoter region before RNAP can initiate the DNA unwinding at that position. RNAP not only initiates RNA transcription, it also guides the nucleotides into position, facilitates attachment and elongation, has intrinsic proofreading and replacement capabilities, and termination recognition capability. In eukaryotes, RNAP can build chains as long as 2.4 million nucleotides.

RNAP produces RNA that, functionally, is either for protein coding, i.e. messenger RNA (mRNA); or non-coding (so-called "RNA genes"). At least four functional types of RNA genes exist:

  1. transfer RNA (tRNA) — transfers specific amino acids to growing polypeptide chains at the ribosomal site of protein synthesis during translation;
  2. ribosomal RNA (rRNA) — incorporates into ribosomes;
  3. micro RNA (miRNA) — regulates gene activity; and,
  4. catalytic RNA (ribozyme) — functions as an enzymatically active RNA molecule.

RNA polymerase is essential to life, and is found in all living organisms and many viruses. Depending on the organism, a RNA polymerase can be a protein complex (multi-subunit RNAP) or only consist of one subunit (single-subunit RNAP, ssRNAP), each representing an independent lineage. The former is found in bacteria, archaea, and eukaryotes alike, sharing a similar core structure and mechanism.[1] The latter is found in phages as well as eukaryotic chloroplasts and mitochondria, and is related to modern DNA polymerases.[2] Eukaryotic and archaeal RNAPs have more subunits than bacterial ones do, and are controlled differently.

Bacteria and archaea only have one RNA polymerase. Eukaryotes have multiple types of nuclear RNAP, each responsible for synthesis of a distinct subset of RNA:

Structure[edit]

T. aquaticus RNA polymerase core (PDB 1HQM).

Yeast RNA polymerase II core (PDB 1WCM).

Homologous subunits are colored the same:[1]α1/RPB3 – orange, α2/RPB11 – yellow, β/RPB2 – wheat, β'/RPB1 – red, ω/RPB6 – pink.

The 2006 Nobel Prize in Chemistry was awarded to Roger D. Kornberg for creating detailed molecular images of RNA polymerase during various stages of the transcription process.[3]

In most prokaryotes, a single RNA polymerase species transcribes all types of RNA. RNA polymerase "core" from E. coli consists of five subunits: two alpha (α) subunits of 36 kDa, a beta (β) subunit of 150 kDa, a beta prime subunit (β′) of 155 kDa, and a small omega (ω) subunit. A sigma (σ) factor binds to the core, forming the holoenzyme. After transcription starts, the factor can unbind and let the core enzyme proceed with its work.[4][5] The core RNA polymerase complex forms a "crab claw" or "clamp-jaw" structure with an internal channel running along the full length.[6] Eukaryotic and archaeal RNA polymerases have a similar core structure and work in a similar manner, although they have many extra subunits.[7]

All RNAPs contain metal cofactors, in particular zinc and magnesium cations which aid in the transcription process.[8][9]

Function[edit]

An electron-micrographof DNA strandsdecorated by hundreds of RNAP molecules too small to be resolved. Each RNAP is transcribing an RNA strand, which can be seen branching off from the DNA. "Begin" indicates the 3' endof the DNA, where RNAP initiates transcription; "End" indicates the 5' end, where the longer RNA molecules are completely transcribed.

Control of the process of gene transcription affects patterns of gene expression and, thereby, allows a cell to adapt to a changing environment, perform specialized roles within an organism, and maintain basic metabolic processes necessary for survival. Therefore, it is hardly surprising that the activity of RNAP is long, complex, and highly regulated. In Escherichia coli bacteria, more than 100 transcription factors have been identified, which modify the activity of RNAP.[10]

RNAP can initiate transcription at specific DNA sequences known as promoters. It then produces an RNA chain, which is complementary to the template DNA strand. The process of adding nucleotides to the RNA strand is known as elongation; in eukaryotes, RNAP can build chains as long as 2.4 million nucleotides (the full length of the dystrophin gene). RNAP will preferentially release its RNA transcript at specific DNA sequences encoded at the end of genes, which are known as terminators.

Products of RNAP include:

RNAP accomplishes de novo synthesis. It is able to do this because specific interactions with the initiating nucleotide hold RNAP rigidly in place, facilitating chemical attack on the incoming nucleotide. Such specific interactions explain why RNAP prefers to start transcripts with ATP (followed by GTP, UTP, and then CTP). In contrast to DNA polymerase, RNAP includes helicase activity, therefore no separate enzyme is needed to unwind DNA.

Action[edit]

See also: Transcription (biology) § Major steps

Initiation[edit]

RNA polymerase binding in bacteria involves the sigma factor recognizing the core promoter region containing the −35 and −10 elements (located before the beginning of sequence to be transcribed) and also, at some promoters, the α subunit C-terminal domain recognizing promoter upstream elements.[11] There are multiple interchangeable sigma factors, each of which recognizes a distinct set of promoters. For example, in E. coli, σ70 is expressed under normal conditions and recognizes promoters for genes required under normal conditions ("housekeeping genes"), while σ32 recognizes promoters for genes required at high temperatures ("heat-shock genes"). In archaea and eukaryotes, the functions of the bacterial general transcription factor sigma are performed by multiple general transcription factors that work together. The RNA polymerase-promoter closed complex is usually referred to as the "transcription preinitiation complex."[12][13]

After binding to the DNA, the RNA polymerase switches from a closed complex to an open complex. This change involves the separation of the DNA strands to form an unwound section of DNA of approximately 13 bp, referred to as the "transcription bubble". Supercoiling plays an important part in polymerase activity because of the unwinding and rewinding of DNA. Because regions of DNA in front of RNAP are unwound, there are compensatory positive supercoils. Regions behind RNAP are rewound and negative supercoils are present.[13]

Promoter escape[edit]

RNA polymerase then starts to synthesize the initial DNA-RNA heteroduplex, with ribonucleotides base-paired to the template DNA strand according to Watson-Crick base-pairing interactions. As noted above, RNA polymerase makes contacts with the promoter region. However these stabilizing contacts inhibit the enzyme's ability to access DNA further downstream and thus the synthesis of the full-length product. In order to continue RNA synthesis, RNA polymerase must escape the promoter. It must maintain promoter contacts while unwinding more downstream DNA for synthesis, "scrunching" more downstream DNA into the initiation complex.[14] During the promoter escape transition, RNA polymerase is considered a "stressed intermediate." Thermodynamically the stress accumulates from the DNA-unwinding and DNA-compaction activities. Once the DNA-RNA heteroduplex is long enough (~10 bp), RNA polymerase releases its upstream contacts and effectively achieves the promoter escape transition into the elongation phase. The heteroduplex at the active center stabilizes the elongation complex.

However, promoter escape is not the only outcome. RNA polymerase can also relieve the stress by releasing its downstream contacts, arresting transcription. The paused transcribing complex has two options: (1) release the nascent transcript and begin anew at the promoter or (2) reestablish a new 3'OH on the nascent transcript at the active site via RNA polymerase's catalytic activity and recommence DNA scrunching to achieve promoter escape. Abortive initiation, the unproductive cycling of RNA polymerase before the promoter escape transition, results in short RNA fragments of around 9 bp in a process known as abortive transcription. The extent of abortive initiation depends on the presence of transcription factors and the strength of the promoter contacts.[15]

Elongation[edit]

RNA Polymerase II Transcription: the process of transcript elongation facilitated by disassembly of nucleosomes.
RNAP from T. aquaticuspictured during elongation. Portions of the enzyme were made transparent so as to make the path of RNA and DNA more clear. The magnesiumion (yellow) is located at the enzyme active site.

The 17-bp transcriptional complex has an 8-bp DNA-RNA hybrid, that is, 8 base-pairs involve the RNA transcript bound to the DNA template strand.[citation needed] As transcription progresses, ribonucleotides are added to the 3' end of the RNA transcript and the RNAP complex moves along the DNA. The characteristic elongation rates in prokaryotes and eukaryotes are about 10–100 nts/sec.[16]

Aspartyl (asp) residues in the RNAP will hold on to Mg2+ ions, which will, in turn, coordinate the phosphates of the ribonucleotides. The first Mg2+ will hold on to the α-phosphate of the NTP to be added. This allows the nucleophilic attack of the 3'OH from the RNA transcript, adding another NTP to the chain. The second Mg2+ will hold on to the pyrophosphate of the NTP.[17] The overall reaction equation is:

(NMP)n + NTP → (NMP)n+1 + PPi

Fidelity[edit]

Unlike the proofreading mechanisms of DNA polymerase those of RNAP have only recently been investigated. Proofreading begins with separation of the mis-incorporated nucleotide from the DNA template. This pauses transcription. The polymerase then backtracks by one position and cleaves the dinucleotide that contains the mismatched nucleotide. In the RNA polymerase this occurs at the same active site used for polymerization and is therefore markedly different from the DNA polymerase where proofreading occurs at a distinct nuclease active site.[18]

The overall error rate is around 10−4 to 10−6.[19]

Termination[edit]

Main article: Terminator (genetics)

In bacteria, termination of RNA transcription can be rho-dependent or rho-independent. The former relies on the rho factor, which destabilizes the DNA-RNA heteroduplex and causes RNA release.[20] The latter, also known as intrinsic termination, relies on a palindromic region of DNA. Transcribing the region causes the formation of a "hairpin" structure from the RNA transcription looping and binding upon itself. This hairpin structure is often rich in G-C base-pairs, making it more stable than the DNA-RNA hybrid itself. As a result, the 8 bp DNA-RNA hybrid in the transcription complex shifts to a 4 bp hybrid. These last 4 base pairs are weak A-U base pairs, and the entire RNA transcript will fall off the DNA.

Transcription termination in eukaryotes is less well understood than in bacteria, but involves cleavage of the new transcript followed by template-independent addition of adenines at its new 3' end, in a process called polyadenylation.[21]

Other organisms[edit]

Given that DNA and RNA polymerases both carry out template-dependent nucleotide polymerization, it might be expected that the two types of enzymes would be structurally related. However, x-ray crystallographic studies of both types of enzymes reveal that, other than containing a critical Mg2+ ion at the catalytic site, they are virtually unrelated to each other; indeed template-dependent nucleotide polymerizing enzymes seem to have arisen independently twice during the early evolution of cells. One lineage led to the modern DNA polymerases and reverse transcriptases, as well as to a few single-subunit RNA polymerases (ssRNAP) from phages and organelles.[2] The other multi-subunit RNAP lineage formed all of the modern cellular RNA polymerases.[22][1]

Bacteria[edit]

In bacteria, the same enzyme catalyzes the synthesis of mRNA and non-coding RNA (ncRNA).

RNAP is a large molecule. The core enzyme has five subunits (~400 kDa):[23]

  • β': The β' subunit is the largest subunit, and is encoded by the rpoC gene.[24] The β' subunit contains part of the active center responsible for RNA synthesis and contains some of the determinants for non-sequence-specific interactions with DNA and nascent RNA. It is split into two subunits in Cyanobacteria and chloroplasts.[25]
  • β: The β subunit is the second-largest subunit, and is encoded by the rpoB gene. The β subunit contains the rest of the active center responsible for RNA synthesis and contains the rest of the determinants for non-sequence-specific interactions with DNA and nascent RNA.
  • α: The α subunit is the third-largest subunit and is present in two copies per molecule of RNAP, αI and αII (one and two). Each α subunit contains two domains: αNTD (N-Terminal domain) and αCTD (C-terminal domain). αNTD contains determinants for assembly of RNAP. αCTD (C-terminal domain) contains determinants for interaction with promoter DNA, making non-sequence-non-specific interactions at most promoters and sequence-specific interactions at upstream-element-containing promoters, and contains determinants for interactions with regulatory factors.
  • ω: The ω subunit is the smallest subunit. The ω subunit facilitates assembly of RNAP and stabilizes assembled RNAP.[26]

In order to bind promoters, RNAP core associates with the transcription initiation factor sigma (σ) to form RNA polymerase holoenzyme. Sigma reduces the affinity of RNAP for nonspecific DNA while increasing specificity for promoters, allowing transcription to initiate at correct sites. The complete holoenzyme therefore has 6 subunits: β'βαI and αIIωσ (~450 kDa).

Eukaryotes[edit]

Structure of eukaryotic RNA polymerase II (light blue) in complex with α-amanitin(red), a strong poison found in death cap mushroomsthat targets this vital enzyme

Eukaryotes have multiple types of nuclear RNAP, each responsible for synthesis of a distinct subset of RNA. All are structurally and mechanistically related to each other and to bacterial RNAP:

Eukaryotic chloroplasts contain an RNAP very highly similar to bacterial RNAP ("plastid-encoded polymerase, PEP"). They use sigma factors encoded in the nuclear genome.[32]

Chloroplast also contain a second, structurally and mechanistically unrelated, single-subunit RNAP ("nucleus-encoded polymerase, NEP"). Eukaryotic mitochondria use POLRMT (human), a nucleus-encoded single-subunit RNAP.[2] Such phage-like polymerases are referred to as RpoT in plants.[32]

Archaea[edit]

Archaea have a single type of RNAP, responsible for the synthesis of all RNA. Archaeal RNAP is structurally and mechanistically similar to bacterial RNAP and eukaryotic nuclear RNAP I-V, and is especially closely structurally and mechanistically related to eukaryotic nuclear RNAP II.[7][33] The history of the discovery of the archaeal RNA polymerase is quite recent. The first analysis of the RNAP of an archaeon was performed in 1971, when the RNAP from the extreme halophileHalobacterium cutirubrum was isolated and purified.[34] Crystal structures of RNAPs from Sulfolobus solfataricus and Sulfolobus shibatae set the total number of identified archaeal subunits at thirteen.[7][35]

Archaea has the subunit corresponding to Eukaryotic Rpb1 split into two. There is no homolog to eukaryotic Rpb9 (POLR2I) in the S. shibatae complex, although TFS (TFIIS homolog) has been proposed as one based on similarity. There is an additional subunit dubbed Rpo13; together with Rpo5 it occupies a space filled by an insertion found in bacterial β' subunits (1,377–1,420 in Taq).[7] An earlier, lower-resolution study on S. solfataricus structure did not find Rpo13 and only assigned the space to Rpo5/Rpb5. Rpo3 is notable in that it's an iron–sulfur protein. RNAP I/III subunit AC40 found in some eukaryotes share similar sequences,[35] but does not bind iron.[36] This domain, in either case, serves a structural function.[37]

Archaeal RNAP subunit previously used an "RpoX" nomenclature where each subunit is assigned a letter in a way unrelated to any other systems.[1] In 2009, a new nomenclature based on Eukaryotic Pol II subunit "Rpb" numbering was proposed.[7]

Viruses[edit]

T7 RNA polymerase producing a mRNA (green) from a DNA template. The protein is shown as a purple ribbon. Image derived from PDB 1MSW

Orthopoxviruses and some other nucleocytoplasmic large DNA viruses synthesize RNA using a virally encoded multi-subunit RNAP. They are most similar to eukaryotic RNAPs, with some subunits minified or removed.[38] Exactly which RNAP they are most similar to is a topic of debate.[39] Most other viruses that synthesize RNA use unrelated mechanics.

Many viruses use a single-subunit DNA-dependent RNAP (ssRNAP) that is structurally and mechanistically related to the single-subunit RNAP of eukaryotic chloroplasts (RpoT) and mitochondria (POLRMT) and, more distantly, to DNA polymerases and reverse transcriptases. Perhaps the most widely studied such single-subunit RNAP is bacteriophageT7 RNA polymerase. ssRNAPs cannot proofread.[2]

B. subtilis prophage SPβ uses YonO, a homolog of the β+β' subunits of msRNAPs to form a monomeric (both barrels on the same chain) RNAP distinct from the usual "right hand" ssRNAP. It probably diverged very long ago from the canonical five-unit msRNAP, before the time of the last universal common ancestor.[40][41]

Other viruses use a RNA-dependent RNAP (an RNAP that employs RNA as a template instead of DNA). This occurs in negative strand RNA viruses and dsRNA viruses, both of which exist for a portion of their life cycle as double-stranded RNA. However, some positive strand RNA viruses, such as poliovirus, also contain RNA-dependent RNAP.[42]

History[edit]

RNAP was discovered independently by Charles Loe, Audrey Stevens, and Jerard Hurwitz in 1960.[43] By this time, one half of the 1959 Nobel Prize in Medicine had been awarded to Severo Ochoa for the discovery of what was believed to be RNAP,[44] but instead turned out to be polynucleotide phosphorylase.

Purification[edit]

RNA polymerase can be isolated in the following ways:

And also combinations of the above techniques.

See also[edit]

References[edit]

  1. ^ abcdWerner F, Grohmann D (February 2011). "Evolution of multisubunit RNA polymerases in the three domains of life". Nature Reviews. Microbiology. 9 (2): 85–98. doi:10.1038/nrmicro2507. PMID 21233849. S2CID 30004345. See also Cramer 2002: Cramer P (2002). "Multisubunit RNA polymerases". Curr Opin Struct Biol. 12 (1): 89–97. doi:10.1016/s0959-440x(02)00294-4. PMID 11839495.
  2. ^ abcdCermakian N, Ikeda TM, Miramontes P, Lang BF, Gray MW, Cedergren R (December 1997). "On the evolution of the single-subunit RNA polymerases". Journal of Molecular Evolution. 45 (6): 671–81. Bibcode:1997JMolE..45..671C. CiteSeerX 10.1.1.520.3555. doi:10.1007/PL00006271. PMID 9419244. S2CID 1624391.
  3. ^Nobel Prize in Chemistry 2006
  4. ^Griffiths AJF, Miller JH, Suzuki DT, et al. An Introduction to Genetic Analysis. 7th edition. New York: W. H. Freeman; 2000. Chapter 10.
  5. ^Finn RD, Orlova EV, Gowen B, Buck M, van Heel M (December 2000). "Escherichia coli RNA polymerase core and holoenzyme structures". The EMBO Journal. 19 (24): 6833–44. doi:10.1093/emboj/19.24.6833. PMC 305883. PMID 11118218.
  6. ^Zhang G, Campbell EA, Minakhin L, Richter C, Severinov K, Darst SA (September 1999). "Crystal structure of Thermus aquaticus core RNA polymerase at 3.3 A resolution". Cell. 98 (6): 811–24. doi:10.1016/S0092-8674(00)81515-9. PMID 10499798.
  7. ^ abcdeKorkhin Y, Unligil UM, Littlefield O, Nelson PJ, Stuart DI, Sigler PB, Bell SD, Abrescia NG (May 2009). "Evolution of complex RNA polymerases: the complete archaeal RNA polymerase structure". PLOS Biology. 7 (5): e1000102. doi:10.1371/journal.pbio.1000102. PMC 2675907. PMID 19419240.
  8. ^Alberts B (2014-11-18). Molecular biology of the cell (Sixth ed.). New York, NY. ISBN . OCLC 887605755.
  9. ^Markov D, Naryshkina T, Mustaev A, Severinov K (September 1999). "A zinc-binding site in the largest subunit of DNA-dependent RNA polymerase is involved in enzyme assembly". Genes & Development. 13 (18): 2439–48. doi:10.1101/gad.13.18.2439. PMC 317019. PMID 10500100.
  10. ^Ishihama A (2000). "Functional modulation of Escherichia coli RNA polymerase". Annual Review of Microbiology. 54: 499–518. doi:10.1146/annurev.micro.54.1.499. PMID 11018136.
  11. ^InterPro: IPR011260
  12. ^Roeder RG (November 1991). "The complexities of eukaryotic transcription initiation: regulation of preinitiation complex assembly". Trends in Biochemical Sciences. 16 (11): 402–8. doi:10.1016/0968-0004(91)90164-Q. PMID 1776168.
  13. ^ abWatson JD, Baker TA, Bell SP, Gann AA, Levine M, Losick RM (2013). Molecular Biology of the Gene (7th ed.). Pearson.
  14. ^Revyakin A, Liu C, Ebright RH, Strick TR (November 2006). "Abortive initiation and productive initiation by RNA polymerase involve DNA scrunching". Science. 314 (5802): 1139–43. Bibcode:2006Sci...314.1139R. doi:10.1126/science.1131398. PMC 2754787. PMID 17110577.
  15. ^Goldman SR, Ebright RH, Nickels BE (May 2009). "Direct detection of abortive RNA transcripts in vivo". Science. 324 (5929): 927–8. Bibcode:2009Sci...324..927G. doi:10.1126/science.1169237. PMC 2718712. PMID 19443781.
  16. ^Milo R, Philips R. "Cell Biology by the Numbers: What is faster, transcription or translation?". book.bionumbers.org. Archived from the original on 20 April 2017. Retrieved 8 March 2017.
  17. ^Svetlov V, Nudler E (January 2013). "Basic mechanism of transcription by RNA polymerase II". Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1829 (1): 20–8. doi:10.1016/j.bbagrm.2012.08.009. PMC 3545073. PMID 22982365.
  18. ^Sydow JF, Cramer P (December 2009). "RNA polymerase fidelity and transcriptional proofreading"(PDF). Current Opinion in Structural Biology. 19 (6): 732–9. doi:10.1016/j.sbi.2009.10.009. hdl:11858/00-001M-0000-0015-837E-8. PMID 19914059.
  19. ^Philips R, Milo R. "What is the error rate in transcription and translation?". Retrieved 26 March 2019.
  20. ^Richardson JP (September 2002). "Rho-dependent termination and ATPases in transcript termination". Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1577 (2): 251–260. doi:10.1016/S0167-4781(02)00456-6. PMID 12213656.
  21. ^Lykke-Andersen S, Jensen TH (October 2007). "Overlapping pathways dictate termination of RNA polymerase II transcription". Biochimie. 89 (10): 1177–82. doi:10.1016/j.biochi.2007.05.007. PMID 17629387.
  22. ^Stiller JW, Duffield EC, Hall BD (September 1998). "Amitochondriate amoebae and the evolution of DNA-dependent RNA polymerase II". Proceedings of the National Academy of Sciences of the United States of America. 95 (20): 11769–74. Bibcode:1998PNAS...9511769S. doi:10.1073/pnas.95.20.11769. PMC 21715. PMID 9751740.
  23. ^Ebright RH (December 2000). "RNA polymerase: structural similarities between bacterial RNA polymerase and eukaryotic RNA polymerase II". Journal of Molecular Biology. 304 (5): 687–98. doi:10.1006/jmbi.2000.4309. PMID 11124018.
  24. ^Monastyrskaya GS, Gubanov VV, Guryev SO, Salomatina IS, Shuvaeva TM, Lipkin VM, Sverdlov ED (July 1982). "The primary structure of E. coli RNA polymerase, Nucleotide sequence of the rpoC gene and amino acid sequence of the beta'-subunit". Nucleic Acids Research. 10 (13): 4035–44. doi:10.1093/nar/10.13.4035. PMC 320776. PMID 6287430.
  25. ^Bergsland KJ, Haselkorn R (June 1991). "Evolutionary relationships among eubacteria, cyanobacteria, and chloroplasts: evidence from the rpoC1 gene of Anabaena sp. strain PCC 7120". Journal of Bacteriology. 173 (11): 3446–55. doi:10.1128/jb.173.11.3446-3455.1991. PMC 207958. PMID 1904436.
  26. ^Mathew R, Chatterji D (October 2006). "The evolving story of the omega subunit of bacterial RNA polymerase". Trends in Microbiology. 14 (10): 450–5. doi:10.1016/j.tim.2006.08.002. PMID 16908155.
  27. ^Grummt I (1999). Regulation of mammalian ribosomal gene transcription by RNA polymerase I. Progress in Nucleic Acid Research and Molecular Biology. 62. pp. 109–54. doi:10.1016/S0079-6603(08)60506-1. ISBN . PMID 9932453.
  28. ^Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek SH, Kim VN (October 2004). "MicroRNA genes are transcribed by RNA polymerase II". The EMBO Journal. 23 (20): 4051–60. doi:10.1038/sj.emboj.7600385. PMC 524334. PMID 15372072.
  29. ^Willis I.M. (February 1993). "RNA polymerase III. Genes, factors and transcriptional specificity". Eur. J. Biochem. 212 (1): 1–11. doi:10.1111/j.1432-1033.1993.tb17626.x. PMID 8444147.
  30. ^Herr AJ, Jensen MB, Dalmay T, Baulcombe DC (April 2005). "RNA polymerase IV directs silencing of endogenous DNA". Science. 308 (5718): 118–20. Bibcode:2005Sci...308..118H. doi:10.1126/science.1106910. PMID 15692015. S2CID 206507767.
  31. ^Wierzbicki AT, Ream TS, Haag JR, Pikaard CS (May 2009). "RNA polymerase V transcription guides ARGONAUTE4 to chromatin". Nature Genetics. 41 (5): 630–4. doi:10.1038/ng.365. PMC 2674513. PMID 19377477.
  32. ^ abSchweer J, Türkeri H, Kolpack A, Link G (December 2010). "Role and regulation of plastid sigma factors and their functional interactors during chloroplast transcription - recent lessons from Arabidopsis thaliana". European Journal of Cell Biology. 89 (12): 940–6. doi:10.1016/j.ejcb.2010.06.016. PMID 20701995.
  33. ^Werner F (September 2007). "Structure and function of archaeal RNA polymerases". Molecular Microbiology. 65 (6): 1395–404. doi:10.1111/j.1365-2958.2007.05876.x. PMID 17697097.
  34. ^Louis BG, Fitt PS (February 1971). "Nucleic acid enzymology of extremely halophilic bacteria. Halobacterium cutirubrum deoxyribonucleic acid-dependent ribonucleic acid polymerase". The Biochemical Journal. 121 (4): 621–7. doi:10.1042/bj1210621. PMC 1176638. PMID 4940048.
  35. ^ abHirata A, Klein BJ, Murakami KS (February 2008). "The X-ray crystal structure of RNA polymerase from Archaea". Nature. 451 (7180): 851–4. Bibcode:2008Natur.451..851H. doi:10.1038/nature06530. PMC 2805805. PMID 18235446.
  36. ^Fernández-Tornero C, Moreno-Morcillo M, Rashid UJ, Taylor NM, Ruiz FM, Gruene T, Legrand P, Steuerwald U, Müller CW (October 2013). "Crystal structure of the 14-subunit RNA polymerase I". Nature. 502 (7473): 644–9. Bibcode:2013Natur.502..644F. doi:10.1038/nature12636. PMID 24153184. S2CID 205235881.
  37. ^Jennings ME, Lessner FH, Karr EA, Lessner DJ (February 2017). "The [4Fe-4S] clusters of Rpo3 are key determinants in the post Rpo3/Rpo11 heterodimer formation of RNA polymerase in Methanosarcina acetivorans". MicrobiologyOpen. 6 (1): e00399. doi:10.1002/mbo3.399. PMC 5300874. PMID 27557794.
  38. ^Mirzakhanyan Y, Gershon PD (September 2017). "Multisubunit DNA-Dependent RNA Polymerases from Vaccinia Virus and Other Nucleocytoplasmic Large-DNA Viruses: Impressions from the Age of Structure". Microbiology and Molecular Biology Reviews. 81 (3). doi:10.1128/MMBR.00010-17. PMC 5584312. PMID 28701329.
  39. ^Guglielmini J, Woo AC, Krupovic M, Forterre P, Gaia M (September 2019). "Diversification of giant and large eukaryotic dsDNA viruses predated the origin of modern eukaryotes". Proceedings of the National Academy of Sciences of the United States of America. 116 (39): 19585–19592. doi:10.1073/pnas.1912006116. PMC 6765235. PMID 31506349.
  40. ^Forrest D, James K, Yuzenkova Y, Zenkin N (June 2017). "Single-peptide DNA-dependent RNA polymerase homologous to multi-subunit RNA polymerase". Nature Communications. 8: 15774. Bibcode:2017NatCo...815774F. doi:10.1038/ncomms15774. PMC 5467207. PMID 28585540.
  41. ^Sauguet L (September 2019). "The Extended "Two-Barrel" Polymerases Superfamily: Structure, Function and Evolution". Journal of Molecular Biology. 431 (20): 4167–4183. doi:10.1016/j.jmb.2019.05.017. PMID 31103775.
  42. ^Ahlquist P (May 2002). "RNA-dependent RNA polymerases, viruses, and RNA silencing". Science. 296 (5571): 1270–3. Bibcode:2002Sci...296.1270A. doi:10.1126/science.1069132. PMID 12016304. S2CID 42526536.
  43. ^Hurwitz J (December 2005). "The discovery of RNA polymerase". The Journal of Biological Chemistry. 280 (52): 42477–85. doi:10.1074/jbc.X500006200. PMID 16230341.
  44. ^Nobel Prize 1959
  45. ^Kelly JL, Lehman IR (August 1986). "Yeast mitochondrial RNA polymerase. Purification and properties of the catalytic subunit". The Journal of Biological Chemistry. 261 (22): 10340–7. doi:10.1016/S0021-9258(18)67529-5. PMID 3525543.
  46. ^Honda A, Mukaigawa J, Yokoiyama A, Kato A, Ueda S, Nagata K, Krystal M, Nayak DP, Ishihama A (April 1990). "Purification and molecular structure of RNA polymerase from influenza virus A/PR8". Journal of Biochemistry. 107 (4): 624–8. doi:10.1093/oxfordjournals.jbchem.a123097. PMID 2358436.
  47. ^Hager DA, Jin DJ, Burgess RR (August 1990). "Use of Mono Q high-resolution ion-exchange chromatography to obtain highly pure and active Escherichia coli RNA polymerase". Biochemistry. 29 (34): 7890–4. doi:10.1021/bi00486a016. PMID 2261443.

External links[edit]

(Wayback Machine copy)

This article incorporates text from the public domain Pfam and InterPro: IPR011773

Sours: https://en.wikipedia.org/wiki/RNA_polymerase

RNA Polymerase: Function and Definition

Ribonucleic Acid (RNA) polymerase is an intermediary enzyme responsible for processing gene sequences into RNA-based genetic material that can be utilized in protein synthesis. In this article, we define RNA polymerase and further explore its various functions throughout cell biology.

What is RNA polymerase?


RNA polymerase is a multi-unit enzyme that synthesizes RNA molecules from a template of DNA through a process called transcription. The transcription of genetic informationinto RNA is the first step in gene expression that precedes translation, the process of decoding RNA into proteins.

RNA polymerase structure and function (in transcription)


The RNA polymerase enzyme is a large complex made up of multiple subunits1. The prokaryotic form of RNA polymerase has four subunits capable of transcribing all types of RNA. In eukaryotes, these enzymes have eight or more subunits that facilitate the attachment and processing of DNA throughout transcription.
RNA polymerase in action


The three stages of transcription involve various functions of RNA polymerase that result in the synthesis of RNA:

1. Initiation begins when RNA polymerase wraps around the promoter region of DNA. The promoter is a DNA sequence that guides RNA polymerase on where to bind upstream of a gene. While prokaryotic RNA polymerase can directly bind to DNA promoter sequences, eukaryotic forms require the assistance of transcription factors for initial binding. Once RNA polymerase successfully binds DNA at the targeted promoter region, the enzyme can continue with the second stage of transcription.

2. Elongation commences when RNA polymerase unwinds double-stranded DNA into two single strands. These DNA strands are used as genetic templates for RNA synthesis. As the DNA template strand moves through the RNA polymerase it builds an RNA strand that is complimentary to the transcribed DNA strand.

3. Termination is the final step of transcription. Once RNA polymerase encounters a terminator sequence or signal, it stops adding complementary nucleotides to the RNA strand. This is followed by the release of the RNA transcript, which marks the end of transcription for that template of DNA.

What are the different types of RNA polymerase?


While prokaryotes like bacteria have one RNA polymerase that transcribes all types of RNA, eukaryotes like plants and mammals can have numerous forms of RNA polymerase.

RNA polymerase I


RNA polymerase I2is responsible for synthesizing most ribosomal RNA (rRNA) transcripts. These transcripts are produced within the nucleolus, a region within the nucleus where ribosomes are assembled. The availability of rRNA molecules produced by RNA polymerase can impact essential functions of cell biology since these transcripts are directly involved with the production of ribosomes.

RNA polymerase II


RNA polymerase II3transcribes protein-coding genes into messenger RNA (mRNA). This 12-subunit enzyme works as a complex that directly influences gene expression through its production of pre-mRNA transcripts. Once the pre-mRNAs are released by RNA polymerase II within the nucleus, biochemical modifications prepare these transcripts for translation. RNA polymerase II also produces micro RNA (miRNA) molecules. These non-coding transcripts can mediate gene expression and the activity of mRNAs after transcription.

RNA polymerase III


RNA polymerase III2transcribes rRNA genes into small RNAs like transfer RNA (tRNA) and 5S rRNA. These smaller RNA transcripts play a role in normal cell function throughout the nucleus and cytoplasm.

RNA polymerase IV and V


Exclusively found in plants, RNA polymerase IV and V are transcription enzymes that evolved as specialized forms of RNA polymerase II4. Both enzymes produce small interfering RNA (siRNA) transcripts, which play a role in the silencing of plant genes.

RNA polymerase vs DNA polymerase


DNA polymerase synthesizes double-stranded DNA molecules from unwound DNA strands during replication. Even though the end products of replication and transcription are different, they both work upon DNA by adding nucleotides in the same 5’ to 3’ direction. In contrast with RNA polymerase, DNA Polymerase is semi-conserved process that utilizes both strands of a double-stranded DNA molecule as a template for replication.

Comparison

RNA Polymerase

DNA Polymerase

Function

Transcription of DNA

Replication of DNA

Purpose

To make RNA copies of genes

To copy the entire genome

Time of occurrence

Used in transcription during G phase(s)

Used in replication during S phase

Primer

Not required for transcription

Required for initiation of replication

Base pairs used to synthesize product

Adenine, Guanine, Cytosine and Uracil

Adenine, Guanine, Cytosine and Thymine

Resulting product

Single-stranded RNAs (e.g. mRNA)

Double-stranded DNAs


RNA polymerase and drugs


RNA polymerase is an attractive target for drug development due to its ubiquitous presence and function throughout life. The biochemical differences in RNA polymerase between prokaryotes and eukaryotes allow for specific drugs that target microbial RNA polymerases without any interaction with our own.

Several antimicrobial drugs function as RNA polymerase inhibitors by blocking bacterial or viral enzyme activity during one stage of transcription. For example, the rifamycins5are a group of bacterial antibiotics that inhibit elongation by blocking the exit channel of RNA polymerase. These drugs are commonly used to treat challenging infections caused by leprosy and tuberculosis.

References:

1.      Mooney RA, Landick R. RNA polymerase unveiled. Cell. 1999;98(6):687-690. doi:10.1016/s0092-8674(00)81483-x.

2.      Khatter H, Vorländer MK, Müller CW. RNA polymerase I and III: similar yet unique. Curr Opin Struct Biol. 2017;47:88-94. doi:10.1016/j.sbi.2017.05.008.

3.      Schier AC, Taatjes DJ. Structure and mechanism of the RNA polymerase II transcription machinery. Genes Dev. 2020;34(7-8):465-488. doi:10.1101/gad.335679.119.

4.      McKinlay A, Podicheti R, Wendte JM, Cocklin R, Rusch DB. RNA polymerases IV and V influence the 3' boundaries of Polymerase II transcription units in Arabidopsis. RNA Biol. 2018;15(2):269-279. doi:10.1080/15476286.2017.1409930.

5.      Sensi P (1983). "History of the development of rifampin". Reviews of Infectious Diseases. 5 Suppl 3: S402–6. doi:10.1093/clinids/5.supplement_3.s402. PMID 6635432

Sours: https://www.technologynetworks.com/genomics/articles/rna-polymerase-function-and-definition-346823

Polymerase function rna

She shouted cheerfully. - Linda is great. Just super. Therefore, we continue to shoot further.

DNA Polymerase vs RNA Polymerase

A short wave of tenderness pushed Shadry gently into her heart. Suddenly the clearing was covered by the dusk of a cloud that blocked the. Light.

You will also like:

Then I said that I was very tired and wanted to sleep, but he had to go. He tried to assure me that in fifteen minutes he would be ready again, but I showed him out the door. That's all. After this we were silent for a long time. Surprisingly, I did not have a feeling of jealousy, on the contrary, I had a feeling to provoke this situation again, especially.



39240 39241 39242 39243 39244